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DEVELOPMENTAL AND MOLECULAR FUNCTIONS OF PLAKOPHILIN-3 
 
William Muñoz, Ph.D. 
Supervisory Professor: Pierre D. McCrea, Ph.D. 
 
 Plakophilin-3, the less studied member of the plakophilin-catenin 
subfamily, and the larger catenin family, binds directly to desmosomal cadherin 
cytoplasmic domains and enhances desmosome formation and stability. In 
mammals, plakophilin-3 is expressed at the highest levels in desmosome-
enriched tissues such as epithelia, with the knock-out in mice producing 
corresponding reductions in ectodermal integrity. In tissue, cellular and 
intracellular contexts where plakophilin-3 is not at the desmosomal plaque, little 
is known about its functions in the cytoplasm or nucleus, where it also localizes. 
 My work employed embryos of the amphibian, Xenopus laevis, to examine 
plakophilin-3’s developmental roles. I first evaluated the expression pattern of 
endogenous plakophilin-3 mRNA and protein, revealing two principal and 
differentially expressed isoforms, and an enrichment in neural tissues as well as 
various epithelial structures. Further, despite conflicting reports on plakophilin-3’s 
nuclear localization, I showed that plakophilin-3 consistently localizes to the 
nucleus in both Xenopus naive ectoderm (animal caps) and mouse embryonic 
stem cells. To assess the in vivo functions of plakophilin-3, I employed sequence 
specific anti-sense morpholinos to knock-down its gene products. This resulted in 
developmental defects in the ectoderm, heart, the formation or maintenance of 
cilia, tactile sensation, neural crest establishment and migration, and the 
peripheral nervous system. These phenotypes were specific based upon the use 
vii 
 
of distinct non-overlapping morpholinos, and in the case of neural crest, the use 
of rescue experiments with morpholino-resistant plakophilin-3 mRNA. As noted 
below, the delineation of which phenotypes result from plakophilin-3's functions 
at the desmosome, or in the cytoplasm, versus or in addition to those in the 
nucleus, is a point of continuing interest. My results in all cases point to 
plakophilin-3’s essential roles in Xenopus development. 
 In probing for novel plakophilin-3 actions in the nucleus as well as 
elsewhere in the cell, I performed a yeast two-hybrid screening of a mouse brain 
cDNA library, resolving and then validating its interaction with ETV1. ETV1 is an 
ETS transcription factor family member with important roles in neural 
development as well as human disease progression. Plakophilin-3’s interaction 
with ETV1 was confirmed using biochemical, functional, and developmental 
assays that centered ultimately upon plakophilin-3’s ability to regulate ETV1 
transcriptional activity. These findings reveal the first sequence specific 
transcription factor to bind a member of the plakophilin-catenin subfamily.  
 Together, my work supports plakophilin-3’s essential roles in amphibian 
development, and shows plakophilin-3’s biochemical and functional association 
with ETV1. In a wider context, it strengthens the view that many (perhaps all?) 
catenin proteins play key roles at both cell-cell junctions and in the nucleus, as 
well as elsewhere in the cell, and raises the longer-term question of if such 
relationships might assist in integrating information across distinct cellular 
compartments. 
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Chapter I 
 
Introduction 
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Cadherins and catenins 
 
 Cadherins are calcium-dependent cell adhesion molecules best known for 
their roles in mediating cell-cell adhesions [1]. While the cadherin family consists 
of more than a hundred members, most can be characterized by an extracellular 
domain, a single transmembrane domain and a cytoplasmic domain [2]. The 
cadherin family is divided into several sub-families including: the classical 
cadherins, the desmosomal cadherins, and the protocadherins, among others. 
The classical and desmosomal cadherins are the central cell-cell adhesive 
components of the adherens junctions and desmosomes, respectively, along with 
their associated catenins. Such cadherin-catenin complexes, and their 
associated larger cytoskeletal (etc.) structures, have significant effects on the 
formation and maintenance of tissue architecture throughout the body [3,4]. 
Further, defects in these components or their functions contribute to pathology, 
including tumor progression and metastasis [5-10]. 
 
Catenins were initially defined for their interaction with cadherins at cell 
borders [11], and all, with the exception of alpha-catenin, possess an Armadillo-
domain composed of either nine or twelve repeats (each of approximately 42 
amino acids) [12-18]. Based upon overall sequence similarity, the size of the 
Armadillo-domain and the region of the cadherin cyto-domain to which they bind, 
the catenin family has been divided into three sub-families: the beta-catenin 
subfamily (beta-catenin and plakoglobin/ gamma-catenin), the p120-catenin sub-
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family [p120-catenin, ARVCF (Armadillo repeat gene deleted in velocardiofacial 
syndrome), delta-catenin, and p0071], and the Plakophilin (Pkp) subfamily (Pkps 
1 to 3) (Figure 1) [19-21]. The catenins have evolved in some cases to have 
various other protein binding domains, such as a carboxyl-terminal PDZ motif 
(beta-catenin, ARVCF, delta-catenin, and p0071 ) and a coiled-coiled domain 
positioned upstream of the Armadillo domain (only in the p120 subfamily) [20]. 
Especially through the Armadillo-domain, various protein-protein interactions 
occur. The best characterized of these interactions are with the classical 
cadherins of the adherens junction (a site of cell-cell adhesion), where the 
Armadillo domain of a beta-catenin subfamily member associates with the 
membrane-distal cytoplasmic tail of the cadherin, and a p120-catenin subfamily 
member binds with the membrane-proximal region [22-27]. The Pkp catenins 
localize at desmosomes, specialized sites of cell-cell adhesion most prominent in 
mechanically stressed tissues,interacting through their amino terminal region 
(rather than their Armadillo-domain) to the cytoplasmic tail of desmosomal 
cadherins [16,20,28,29]. Interestingly, the plakoglobin-catenin (gamma-catenin) 
has been shown to bind cadherins of both the adherens and desmosomal 
junctions [21,30]. 
 
 Catenins have numerous roles throughout the cell (Figure 2). At the 
cadherin complex they contribute to cadherin stability (p120- and Pkp sub-
families) [5,28,29,31-34]. The p120 subfamily is predominately thought to 
promote cadherin stability by inhibiting clathrin-mediated endocytosis of the  
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Figure 1.  Schematic diagram of the catenin family. 
 
Depicted are catenins divided into their individual sub-families including the beta-
catenin, p120-catenin, and Pkp subfamilies. 
5 
 
 
 
Figure 2. The known roles of p120- and Pkp-catenin subfamily proteins and the 
predicted roles of Pkp-catenin subfamily proteins.  
 
At cell-cell contacts, the p120- and Pkp-catenin subfamily members stabilize the 
cadherin complexes at either the adherens junction or desmosome, respectively. 
p120 sub-family members also modulate small Rho GTPases with early evidence 
suggesting similar roles for Pkp sub-family members. P120-catenin binds to 
transcriptional repressor, Kaiso, de-repressing Kaiso target genes. The Pkps 
localize to the nucleus with nuclear binding partners now being characterized by 
several groups. 
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classical cadherin, where the cadherins are subjected to lysosomal degradation 
[35-37]. The Pkp subfamily members ensure desmosomal cadherin stability by 
promoting the transport of cadherins to the desmosome and providing a scaffold 
for the complex linking the various desmosomal components [16,17,29,32,38-
42]. The catenins also indirectly link either the adherens junctions or 
desmosomal junctions to the cytoskeleton (beta-catenin and Pkp subfamilies), 
enhancing the strength of the junction leading to a junctional-cytoskeletal 
interdependence [16,28,29,32,43-47].  
 
In the cytoplasm, the p120- and Pkp sub-families have been shown to 
modulate the activity of Rho-family GTPases [17,42,48-53]. The p120 subfamily 
modulates Rho family small G proteins, including RhoA, Rac1 and Cdc42- 
affecting cytoskeletal formation, cell motility, and endocytosis [34,48-50,52,54]. 
While not as well understood, Pkps also affect cell shape through a RhoA 
dependent mechanism [55,56]. Initial results indicate Pkp2 regulates RhoA 
activity through the relocalization of active RhoA to intercellular interfaces upon 
cell-cell contact contributing to cortical actin remodeling, having downstream 
effects on desmosome assembly [42].  
 
Finally, most if not all catenins localize to the nucleus [18]. For example, 
significant research has shown that beta-catenin relieves TCF/LEF-mediated 
transcriptional repression following canonical Wnt-pathway activation. p120-
catenin has been shown to bind the transcriptional repressor Kaiso, Glis2 and the 
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REST/CoREST complex [57-60] (Moonsup Lee’s unpublished results). p120-
catenin (isoform1) also appears to respond to canonical Wnt signals by de-
repressing Kaiso gene targets, including some shared with beta-catenin/TCF 
[58,61-66]. In comparison to members of the p120-catenin or beta-catenin 
subfamilies, very little is known about Pkp-catenins' interactions or roles in the 
cytoplasm or nucleus. 
 
Pkp-catenin sub-family 
 
Defects in Pkp expression or function have been linked to several 
developmental diseases, such as skin dysplasia resulting from Pkp1 mutations, 
where hyperkeratinosis and blistering follows impact trauma [7,67-72]. Pkp2 
mutations have been found to contribute to arrhythmogenic right ventricular 
cardiomyopathy (heart failure), in which heart muscle is replaced by a fatty tissue 
[17,73-76]. Interestingly, cancer studies suggest that Pkps have roles as both 
tumor suppressors and oncogenes [10,55,77-80], indicating they may have 
multiple activities to produce these effects.  
 
Pkps form a subfamily of catenins, each containing an Armadillo-repeat 
domain that is structurally homologous to those present in members of the beta-
catenin as well as p120-catenin subfamilies [10,16-18,81,82]. The Pkps consist 
of Pkps-1, -2, and -3 and are characterized by nine Armadillo repeats, a highly 
variable amino terminal domain and a short or absent carboxy terminal domain. 
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Additionally, the Pkps have been identified in a variety of tissues with their 
localization rarely overlapping, suggesting that they may have independent, yet 
complementary roles.  
 
As mentioned earlier, the Pkps assist in assembling and stabilizing 
desmosomal cell-cell junctions through interactions with the cytoplasmic tail of 
desmosomal cadherins (named desmocollins and desmogleins), that span the 
plasma membrane and interact with intracellular desmosomal components such 
as desmoplakin and intermediate filaments [16,32,76,83,84]. These interactions 
aid in connecting desmosomal junctions to the intermediate filament 
cytoskeleton, promoting the physical integrity of multiple tissues subjected to 
mechanical stress [7,28,29,39,45,46,84-87]. While their cytoplasmic functions are 
less clear at present, Pkps are involved in regulating mRNA expression, protein 
translation, the trafficking of desmosomal cadherins and insulin-induced cell 
proliferation [41,80,88,89]. In addition to junctional and cytoplasmic localizations 
and roles, Pkp-catenins have also been reported to localize to the nucleus in 
some contexts [18,40,90-96]. Conceivably, some Pkp roles might later prove to 
be analogous to those of the beta- and p120-catenin subfamily members, in that 
they may associate with transcription-factor partners (e.g. beta-catenin binds/ 
modulates TCF/LEF, and p120-catenin binds/ modulates Kaiso) [57-59]. Thus 
far, the nuclear associations of the Pkps have intriguingly included Pkp1 binding 
to single-stranded DNA and Pkp2 to the RNA polymerase III holoenzyme [97,98]. 
9 
 
The functional roles of these particular nuclear interactions require future 
clarification. 
 
Pkp3 
 
Pkp3 is the least understood member of the Pkp sub-family. Mammalian 
systems have demonstrated that the highest levels of Pkp3 are found in tissues 
enriched for desmosomes, such as in simple epithelia or the living layers of 
stratified epithelia and the epidermis [93,99,100]. However, Pkp3 mRNA is 
expressed in most tissues of mammals [101]. The targeted whole-animal 
knockout of Pkp3 in mice resulted in hair shaft abnormalities, skin inflammatory 
responses, and disruptions of desmosome assembly in the epidermis. As no 
further effects were reported, Pkp3-/- desmosomal defects in mice appear to 
predominate in skin. [102]. However, additional Pkp3 phenotypes may have been 
masked by partial compensation by Pkp1 or 2, given that they each showed 
increased expression in the Pkp3 knockout mouse.  
 
In pathology, Pkp3 misexpression has been associated with non-small cell 
lung carcinomas, squamous cell carcinomas, gastric carcinoma, breast 
carcinoma and adenocarcinomas [55,77,79,103-105]. It has also been shown 
that reduction of Pkp3 levels in HCT116 cells enhances their metastatic potential 
in mice [78].  
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In addition to interactions shared among different Pkp proteins 
(desmosomal cadherins, desmoplakin and plakoglobin), Pkp3 exhibits some 
distinctions. For example, Pkp3 associates with a wider range of desmosomal 
proteins than the other Pkps and has been shown to interact with components of 
stress granules with strong localization to this structure [45,88]. In addition, Pkp3 
has been found to localize to the nucleus under certain conditions in addition to 
other cellular structures [40,95,99]. Prior reports have been inconsistent in 
suggesting that Pkp3 localizes to the nucleus. However, as described below, my 
work demonstrates consistent localization of Pkp3 to the nucleus in two different 
developmental systems and suggests a novel nuclear function. 
 
ETS transcription factor family 
 
 The E twenty-six (ETS) family of proteins, found only in metazoans, 
consists of 28 members in humans. This family is characterized by a conserved 
ETS DNA binding domain, which recognizes DNA with the specific core motif 
sequence 5’-GGA(A/T)-3’ [106-108]. The ETS domain is a variant of the winged 
helix-turn-helix motif, consisting of three alpha-helices on a four beta-sheet 
scaffold forming direct contacts with the core 5’-GGA(A/T)-3’ motif exclusively 
[109]. This family of proteins is divided into numerous sub-families based upon 
sequence similarities in the ETS domain and other conserved domains, including 
the Polyomavirus enhancer activator 3 (PEA3) subfamily described later [110].  
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The diverse functions of this family are reflected in the broad range of 
phenotypes resulting from knockouts in C. elegans,Drosophila and mouse (e.g. 
defects in neuronal connections, fertility, vasculature, hematopoiesis, etc.) 
(reviewed in Hollenhorst et al. 2011) [111-113]. Due to the strong conservation of 
the ETS domain and its structure, there is only minor variance in the DNA-
binding motif preference amongst most of the ETS family in vitro [114], 
suggesting that the diverse roles of ETS proteins may arise from differences in 
their binding partners and changes in the highest-affinity consensus motifs. For 
example, an ETS family member PU.1 regulates a different gene set alone than 
when bound to Pip, a lymphoid-specific co-regulator. [115].  
 
 The PEA3 subfamily, consisting of PEA3, Ets variant gene 1 [ETV1/ER81 
(Ets-related 81)] and ETS variant gene 5 (ETV5), is characterized by two 
autoinhibitory domains flanking the ETS DNA binding domain and an acidic 
domain near the amino-terminus [116]. The autoinhibitory domains are thought to 
fold on each other, obscuring the DNA binding domain from interacting with DNA. 
This autoinhibition can be disrupted by either addition of an antibody specific to 
one of the domains or deletion of one of the autoinhibitory domains, further 
supporting the hypothesis that they cooperate to inhibit DNA binding 
[111,117,118]. Interestingly, all three PEA3 subfamily members contribute to the 
development of neuronal structures [119-123].  
12 
 
ETV1 
 
 ETV1, a PEA3 subfamily member, is known to contribute to the formation 
of dopaminergic neurons through the transcriptional regulation of dopamine 
transport and synthesis genes, and it also contributes to the formation of proper 
connections between group 1a sensory afferents and motor neurons, which 
transduce sensory signals to and from the brain [120,123]. ETV1 knockout in 
mouse results in limb ataxia, loss of coordination, and death by six weeks post-
natal, likely due to an unresolved neural defect [120]. Our work demonstrates 
that overexpression of ETV1 in Xenopus also results in later neurological defects, 
with a loss of eye structures following evagination of the rudimentary eye [124]. 
The results from both mouse and Xenopus suggest that ETV1 is necessary in the 
later stages of neuronal development.  
 
 Examination of tumorigenic cell lines have shown that ETV1 regulates the 
matrix metalloproteinase genes, which are involved in invasion of cells through 
the extracellular matrix and the basement membrane, promoting metastasis 
[125,126]. Also, ETV1 promotes Ewing’s sarcomas through a fusion with the 
Ewing’s sarcoma gene (EWS), and is implicated in promoting the metastasis of 
prostate cancer (reviewed in Oh et al., 2012) [127]. 
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Summary 
 
The Pkp-catenin subfamily has always been shown to have strong 
localization in various cellular compartments, including the desmosomes, the 
cytoplasm and the nucleus, but the functions of Pkps in these compartments 
have remained elusive. Contributing to this, the multiple mammalian Pkp proteins 
derived through evolution have overlapping functions, potentially masking 
knockout phenotypes that would otherwise be readily identified by compensating 
for each other. Altogether, my research has demonstrated the first interaction 
between a plakophilin-catenin (Pkp3) and a site-specific DNA-binding 
transcription factor, ETV1, while demonstrating the necessity of Pkp3 during 
amphibian development. This work should assist in providing an understanding 
of how Pkps influence development and possibly disease as a result of their 
actions in the nuclear compartment. 
14 
 
 
 
Chapter II 
 
Results
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Part One: Characterization of Xenopus Pkp3 
 
Identification of the Xenopus Pkp3 ortholog 
 
Xenopus Pkp3 shares strong similarity (71.2%) with human and mouse 
Pkp3 (Figure 3). The isoform isolated is encoded by 2472 base pairs, 
corresponding to 824 amino acids and a predicted protein molecular mass of 91 
kDa. The sequence has been deposited online as Genbank ID: AF182522. Two 
potential alternative translational start sites were found in the predicted protein 
sequence that reside prior to the Armadillo domain and are conserved in mouse 
(but not human). In contrast to their known or putative relevance in p120-
subfamily biology [81,128], it is unclear at this time if alternative translational start 
sites are employed to generate different Pkp isoforms in vivo. Also found in Pkp3, 
as we recently characterized in some detail for delta-catenin [129], is a 
conserved predicted caspase cleavage site that if employed would generate ~56 
kDa and ~35 kDa Pkp3 fragments. The amino-terminus is serine rich, accounting 
for approximately 15% of the residues in this region, and includes numerous 
potential phosphorylation sites. Overall, Xenopus Pkp3 resembles in its primary 
structure its mammalian counterparts, with caspase cleavage and 
phosphorylation being among possible points of regulation.  
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Figure 3.  Pkp3 domain structure and amino acid sequence alignment.  
(A)  Diagram of Pkp3 protein characteristics. Potential alternative translation 
initiation start sites are indicated with arrows, while a conserved, potential 
caspase cleavage site is labeled with an asterisk. (B)  Sequence alignment of 
Xenopus laevis, human and two isoforms of mouse Pkp3. Identical and similar 
residues are indicated by grey highlighting. The Armadillo domain is underlined. 
Black boxes indicate methionines conserved with mouse that might serve as 
alternative translation initiation sites. Potential caspase cleavage sites are 
labeled with asterisks. 
A 
B 
A 
B 
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Xenopus Pkp3 temporal expression 
 
To evaluate the temporal expression pattern of Pkp3, I performed semi-
quantitative real-time RT-PCR utilizing total mRNA isolated from Xenopus 
embryos. Dissimilar from other characterized catenin mRNAs [34,130-133], 
Xenopus Pkp3 transcript levels appeared to increase rather dramatically (5-10 
fold) following gastrula stages (Figure 4A), suggesting that Pkp3 may act 
predominately later in development. To examine Xenopus Pkp3 at the protein 
level, we generated a rabbit polyclonal antibody directed against its N-terminal 
domain (amino acids 1-350), that precedes the Armadillo domain (Figure 3A). 
The affinity-purified antibody recognizes two Pkp3 protein products migrating at 
approximately 110 kDa and 75 kDa, which are not detected using pre-
immunization sera from the same rabbit (Figure 5). The 110 kDa migrating 
product is larger than predictions based upon the isolated Pkp3 mRNA, 
suggesting that our cloning procedures may have missed a larger alternatively 
spliced mRNA, possibly one including a more upstream translation initiation site. 
Within the p120 subfamily, such alternative splicing is well known to take place 
across various catenin domains [34,134,135]. Finally, a third and larger protein 
product is occasionally (and weakly) detected at approximately 120 kDa. It is 
likely to be a Pkp3 isoform and may arise from an unknown alternative RNA 
splicing event, translation from a more upstream start site, or post-translational 
modification. Via morpholino knockdown of Pkp3 with two independent 
morpholinos, the 110 and 75 kDa bands were demonstrated to be authentic  
18 
 
 
 
 
 
 
A 
B 
19 
 
 
Figure 4.  Xenopus Pkp3 temporal expression profiles.  
 
(A)  Semi-quantitative real-time RT-PCR analyses indicating Pkp3 transcripts are 
deposited maternally at a relatively low level and then levels increase following 
gastrulation. (B)  The 75 kDa Pkp3 protein isoform increases following 
gastrulation, while the 110 kDa isoform exhibits an inverse pattern. The 
polyclonal antibody generated against Xenopus Pkp3 amino acids 1-350 (N-
terminal domain) recognizes Pkp3 protein products migrating at approximately 
110 kDa and 75 kDa. Further, in early development, a fainter and more slowly 
migrating band is detected at approximately 120 kDa. Immuno-blot detection of 
GAPDH serves as a loading control. 
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Figure 5.  Characterization of affinity purified rabbit polyclonal antibodies that are 
directed against the N-terminal domain of Pkp3 (amino acids 1-350).  
 
Immuno-blotting using the noted anti-Pkp3 antibodies specifically revealed 
110 kDa and 75 kDa protein products in Xenopus embryo extracts (stage 25; 
also detected using whole sera). The same bands are not resolved using serum 
collected from the same rabbit prior to immunization. 
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(Figure 10B). With regards to Pkp3 protein levels, I found that consistent with the 
relative abundance of Pkp3 transcripts across developmental stages (Figure 4a), 
the 75 kDa translation product of Pkp3 increases following gastrulation. 
Complementing the temporally increasing expression profile of 75 kDa Pkp3, the 
110 kDa protein product is instead maternally deposited and expression 
decreases following gastrulation (Figure 4B). This suggests the possibility of 
distinct functions of the two isoforms according to developmental stage in 
amphibian development.  
 
Xenopus Pkp3 spatial expression 
 
The spatial expression profile of Pkp3 was obtained through whole-mount 
in situ RNA hybridization of Xenopus embryos at various stages. I used a 
digoxigenin-labeled antisense full-length RNA probe of Pkp3 (Figure 6A a-d). A 
sense negative-control probe was hybridized and processed in parallel, and as 
expected did not produce significant signal intensities (Figure 6A e-h). In 
agreement with my qRT-PCR (Figure 4A), Pkp3 transcripts were less apparent 
prior to neurulation (data not shown), but subsequently become evident in the 
dorsal and anterior regions of neurula stage whole-mount embryos. At tailbud 
stages, embryos show staining in neural and neural crest derived tissues, as well 
as within somites and broad expression across the ectoderm. In particular, I 
observed signals consistent with the brain, eye vesicle and spinal cord, as well 
as the branchial arches. While quite faint, sectioning of these embryos confirmed  
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Figure 6.  Xenopus Pkp3 spatial expression profiles during development.  
 
(A)  Whole-mount in situ RNA hybridization reveals Pkp3 mRNA signals in the 
anterior and dorsal neural fold regions of neurula embryos (subpanel a). At 
elongation stages (stage 22; subpanel b), staining of the skin remains apparent, 
as does a concentration in dorsal structures. At tadpole stages, neural derived 
tissues including the brain, branchial arches and the spinal cord are stained, as 
are somites (subpanels c-d). As a basis for comparison (negative controls), we 
undertook sense-probe hybridizations in parallel (subpanels E-H). (B) Whole 
mount anti-sense in situ staining of tadpole stage embryos, followed by cross-
sectioning and agarose embedding, reveals faint Pkp3 signals in the neural tube 
(arrowhead) relative to the sense (negative) control stained embryos. NT, neural 
tube; NO, notochord. 
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Pkp3 expression in the ectoderm, branchial arches and neural tube (Figure 6B 
and data not shown). 
 
To further examine the spatial profile of Pkp3 protein products, I 
performed immuno-blot analysis of adult Xenopus laevis tissues using our affinity 
purified polyclonal antibody. Consistent with Pkp3’s predominant later expression 
in embryogenesis (Figure 4B), only the 75 kDa Pkp3 product was detected, being 
most prominent in tissues enriched for desmosomes, such as the heart, lung, 
muscle and skin (Figure 7). Following longer exposures of the ECL films, Pkp3 
was also clearly present in the kidney and brain (results not shown). My findings 
indicate that Xenopus Pkp3 is most highly expressed at the mRNA and protein 
levels in desmosome-strengthened tissues, and is also found in tissues of neural 
derivation.  
 
Xenopus Pkp3 subcellular localization 
 
Catenin family members have been shown previously to localize to 
differing subcellular compartments, consistent with even a single catenin’s varied 
functions [17,18,20]. This includes interactions with cadherin cytoplasmic tails at 
cell-cell junctions, modulation of small GTPases and protein translation in the 
cytoplasm, and alterations of gene expression in the nucleus. To assist in 
assessing Pkp3’s subcellular localization, I generated a Myc-Pkp3 fusion 
construct, expressed it at levels similar to endogenous Pkp3 (Figure 8) and  
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Figure 7.  Adult Xenopus Pkp3 spatial expression. 
 
Immuno-blotting on adult Xenopus tissue extracts. We used an affinity purified 
rabbit polyclonal antibody directed against the N-terminal domain of Pkp3, which 
clearly resolved the Pkp3 protein isoform migrating at approximately 75 kDa. This 
product was strongly expressed in heart, lung, muscle and skin. Weak, 
reproducible expression was detected in brain and kidney.   
 
A 
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Figure 8. Expression of exogenous Pkp3-Myc in Xenopus extracts. 
 
Immuno-blots of early neurula and tailbud extracts, showing the level of 
exogenous Myc-tagged Pkp3 relative to endogenous Pkp3 (500pg Pkp3 mRNA 
injection at one-cell stage). 
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examined its distribution in the Xenopus ectoderm of blastula stage embryos 
(animal caps), and late neurula stage embryos. At blastula stage, I found that 
Pkp3 is present at cell-cell borders, along fibrous cytoplasmic structures and in 
the nucleus (Figure 9Aa). In early tailbud, I consistently observed quite faint Pkp3 
localization at cell borders, with even less intensity in the nucleus relative to 
blastula stages (Figure 9Aa’’). Interestingly, I observed more intense punctate 
spots in select smaller cells within the same field that we later confirmed were 
within multiciliated cells intercalating from the sensoral layer of the ectoderm 
(Figure 9Aa’’ and data not shown). Nuclear localization of endogenous Pkp3 was 
likewise easily detected in uninjected embryos (Figure 9B), while cell border 
localization was considerably fainter to absent. This latter observation might arise 
from lesser accessibility of the added antibodies to the endogenous Pkp3 
antigen(s) within mature desmosomal structures. That is, since Pkp3 is known to 
bind multiple desmosomal proteins [45], the exogenous protein might more easily 
decorate desmosomal structures in a manner that leaves the Myc-tag exposed 
for antibody based detection. In summary, my results suggest that Xenopus may 
prove a good model for studying Pkp3’s junctional and/ or cytosolic contributions 
to vertebrate development, and perhaps also its currently understudied nuclear 
functions.  
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Figure 9. Pkp3 subcellular localization.   
 
(A) Following earlier injection of exogenous Myc-tagged Pkp3 mRNA (0.5ng 
injected into one-cell stage embryo), Pkp3 was visualized in the naïve ectoderm 
(animal cap) cells of blastula embryos at the plasma membrane, in the cytoplasm 
along what appear to be fibrous structures (possibly the intermediate filament 
network), and in the nuclear compartment (subpanel a). At late neurula stage the 
exogenous Pkp3 was again detected at the plasma membrane (arrowhead), in 
the nuclear compartment (though much weaker), and as punctate apically 
disposed spots (conceivably basal bodies or other cilia associated structures, 
arrow), in multiciliated cells intercalating upwards from the deeper sensoral layer 
(subpanel a’’). (B) Immuno-fluorescence detection of endogenous Pkp3, using 
the affinity purified rabbit polyclonal antibody we generated. Pkp3 is detected in 
the nucleus of non-dividing cells within blastula-stage ectoderm (animal caps), 
while the secondary antibody alone did not produce a detectable signal (nor did 
additional negative controls; data not shown).  
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Part Two: Developmental Roles of Pkp3-catenin 
 
Knockdown of endogenous Pkp3 upon treatment with morpholinos 
 
The temporal and spatial expression of Pkp3, noted above, suggested that 
Pkp3 might contribute to various embryonic stages and developmental 
processes. To assess this possibility, we designed antisense morpholinos to 
lower endogenous Pkp3 protein expression in Xenopus. Specifically, two 
independent oligonucleotide sequences were designed to compliment either the 
start ATG (MO3), or the proximal 5’ UTR (MO1) of the Pkp3 mRNA (Figure 10A). 
Reducing the probability of off-target effects, the morpholinos employed had no 
discernable complementation to the mRNA of X. laevis Pkp2 or other sequences. 
Further, while X. laevis Pkp1 was not resolved in the existing databases, X. 
tropicalis Pkp1 likewise lacked sequence complementation. To characterize their 
efficacy, the Pkp3 morpholinos were injected at varying doses (1-40ng) into early 
cleavage stage embryos, which were then observed through tadpole stages. 
Immuno-blot assay of extracts obtained from embryos injected at the 1-cell stage 
confirmed that Pkp3 was reproducibly depleted by 40ng of either MO1or MO3 or 
a mixture of the two morpholinos totaling 40ng, but not by the standard control 
(SC) morpholino (Figure 10B). Likewise, the translation of an exogenous Pkp3 
mRNA, that included 90bp of the 5’ UTR, was prevented upon the co-injection of 
either MO1 or MO3 (1ng; Figure 10C). Of note, Pkp2 mRNA and protein levels 
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were not affected by injection of mopholinos directed against Pkp3 (Figure 10B 
and 11). 
 
Pkp3 depletion results in ectodermal fragility  
 
To assess the developmental impact of Pkp3 depletion, I injected MO1 or 
MO3, or both together into the animal pole of 1-cell embryos, or into a single 
blastomere of 2-cell embryos. Based upon gross external observation, these MO-
injected embryos did not present any significant phenotypes until early tailbud 
stages, when hatching from their protective Vitelline envelope normally occurs. In 
contrast to SC injections (negative control), MO1 or MO3 injected embryos 
experienced damage to their surface ectoderm during shedding of the Vitelline 
membrane, which exerts tension and presumably frictional effects upon the 
hatching embryo. The phenotypic penetrance following Pkp3 depletion varied 
from 30-100%, as a function of the particular batch of embryos, amount of 
morpholino and the morpholino employed (Figure 12). To obtain higher resolution 
views of the ectodermal phenotype, we turned to transmission electron 
microscopy. Following use of either of the Pkp3 targeting morpholinos, we 
observed reductions in the size and number of more basally localized 
desmosomal densities (Figure 13). Interestingly, while we do not presently 
understand the underlying basis, ectodermal cells of Pkp3 depleted embryos also 
displayed apically clustered mitochondria, as well as a significantly increased 
number and size of mucus secretory vesicles. Through the use of scanning  
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Figure 10. Two independent morpholinos knockdown Pkp3 protein expression.  
(A) Diagram of morpholino-based depletion strategy. MO 3 targets the Pkp3 
mRNA translational start site and MO 1 targets a non-overlapping upstream 
sequence in the 5’ UTR. Both morpholinos were designed to block translation 
initiation. (B)  Immuno-blotting of hatching embryo extracts (stage 27) confirmed 
reductions of both Pkp3 protein isoforms following morpholino injection, but no 
reductions of Pkp2 protein (40ng of each morpholino when injected individually or 
20ng of each morpholino when injected together into one-cell stage embryos). 
GAPDH serves as a loading control. (C)  Immuno-blotting of blastula extracts 
confirmed the reduced presence of exogenous HA-tagged Pkp3 protein following 
earlier co-injection (one-cell stage) of Pkp3 mRNA (250pg) with even low-doses 
of MO1 or MO3 (1ng of either morpholino). A non-specific band serves as a 
loading control. 
A B 
C 
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Figure 11. Pkp3 depletion does not notably affect Pkp2 mRNA levels.  
 
Following depletion of Pkp3 (40ng MO1 or MO3 into one-cell stage embryos) RT-
PCR was preformed on cDNA derived from stage 27 embryos. No significant 
change was detected in Pkp2 mRNA levels, relative to embryos injected with 
standard control (SC) morpholino. Pkp2 bands were quantified and normalized 
relative to the ODC loading control, with no statistically significant differences 
found. 
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Figure 12.  Depletion of endogenous Pkp3 results in skin fragility.  
 
(A) Injection of MOs 1 or 3 (40ng into one-cell stage embryos) results in skin 
fragility (subpanels b and c, respectively), contributing to what can become lethal 
ectodermal damage sustained as the embryo hatches from the Vitelline 
membrane (higher magnification in subpanels b’, b’’, and c’). Negative control 
embryos injected with standard control morpholino (40ng) did not exhibit 
significant phenotypes (subpanels a-a’). (B) Quantification of the skin fragility 
effects are indicated in subpanel “b”, where P-values indicate statistical 
significance. As indicated, either 40 or 20ng of each morpholino was injected into 
one-cell stage embryos. 
A 
B 
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Figure 13. Depletion of endogenous Pkp3 results in loss of desmosomes, 
increased secretory vesicle size and relocalization of mitochondria.  
 
(A) Skin of tailbud stage embryos injected at one-cell stage with 40 ng standard 
control morpholino (subpanel a) compared to 40 ng MO 1 or 3 injected embryos 
(subpanels b and c, respectively). Pkp3 depleted ectoderm contains fewer 
basally disposed desmosomes (black arrow heads), while in apical regions 
desmosomes appear equally abundant. Note also that in skin of Pkp3 
knockdown embryos, mitochondria have become more apically disposed (white 
arrowheads), and secretory vesicles have become much larger along the apical 
surface (black arrows). (B) High-magnification transmitted electron microscopy 
revealed that the depletion of Pkp3 (subpanels MO1 and MO3) results in reduced 
desmosome size and appearance. For example, MO3 injected embryos exhibit 
some desmosome-like structures where equivalent densities are not always 
properly paired between contacting cells (see arrowheads).
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electron microscopy (Figure 14), the more roughened surface features of 
embryos depleted of Pkp3 (using combined morpholinos), appeared to reflect the 
increased number and sizes of underlying mucus secretory vesicles making 
contact and then fusing with the plasma membrane (compare right-hand panels 
of Figure 14 that shows pocked/ roughened apical surface with panels b and c of 
Figure 13A, showing vesicles making surface contact). Additionally, scanning EM 
revealed defects in the motile cilia present upon multiciliated cells, as evident in 
Figure 14. Such reductions in motile cilia were further reflected in lessened 
immuno-fluorescent intensity when staining for acetylated alpha-tubulin, which is 
commonly used to resolve cilia as well as established neurons (Figure 15). 
Intriguingly, additional immuno-fluorescence analysis suggested that the 
multiciliated cells may themselves be reduced in number, or exhibit delays in 
intercalation upon Pkp3 depletion (data not shown). Finally, we noted that the 
very fine but observable surface demarcation of cell-cell borders within the 
ectoderm became less apparent following Pkp3 depletion (compare especially 
the lower panels of Figure 14).  
 
To briefly survey another tissue dependent upon desmosome function, we 
looked at the heart. Here, we found that Pkp3 depleted embryos surviving 
ectoderm defects exhibited gross reductions in heart size as well as notable 
slowing of the beat rate at tadpole stages (data not shown). In summary, a 
number of phenotypes are apparent in Xenopus embryos depleted of Pkp3. 
While future study will be needed, some outcomes may not be the direct result of  
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Figure 14. Pkp3 depletion alters the morphology of various cellular features. 
 
Scanning electron microscopy revealed altered ectoderm surface features in 
Pkp3 depleted embryos. For example, whereas in control embryos fine 
demarcations can be seen upon close examination to reflect the borders 
between cells, such demarcations are more difficult to discern in Pkp3 depleted 
embryos. Further, we observed increases in the size of what we expect are 
mucus secretory vesicles (pits on the surface), a finding that was likewise 
reflected in transmission electron micrographs (see Figure 11A). Defects in the 
cilia of multiciliated cells were also apparent in Pkp3 morphants. 40ng of each 
morpholino was injected at the one-cell stage. 
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Figure 15. Pkp3 depletion results in reductions of multiciliated cells and neural 
tracts. 
 
Neural processes present in the posterior region (tailbud) of control tailbud stage 
embryos (subpanel a) were reproducibly found to be less apparent and/ or 
foreshortened following Pkp3 depletion (subpanel a’). Morpholinos (40ng each) 
were injected at the one-cell stage. 
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altered desmosome function, such as the noted effects upon vesicle trafficking or 
cilia. 
 
Touch hyposensitivity and neural phenotypes in Pkp3 depleted embryos 
 
Skin fragility was found at varying penetrance in Pkp3 knock down embryos as 
noted, yet more detailed observation further revealed that depleted embryos 
hatch from the Vitelline membrane at later developmental stages than do 
controls. Upon hatching, MO1 or MO3 injected embryos maintained a laterally 
curled appearance, apparently the result of their prolonged entrapment. With 
possible reasons for their extended entrapment discussed below, such embryos 
exhibited a fixed lateral curvature or kink along the anterior-posterior axis (Figure 
16A). Interestingly, if the Vitelline membrane was manually removed at an earlier 
developmental stage to reduce embryo entrapment times, the penetrance of this 
phenotype was significantly lowered (Figure 16B). A further obvious and 
unexpected phenotype was that depleted embryos, importantly including those 
with intact ectoderm, were not responsive to common laboratory stimuli such as 
gentle movement of their incubation dish or a light touch with a pipette tip (Figure 
17 and data not shown). These observations suggested potential defects in 
neural or muscular development or function. Immuno-histochemical examination 
of the somites, early muscular structures, suggested that somite formation was 
not grossly altered (Figure 18). A further functional indication of normal muscle 
capability was that embryos appeared to swim normally following more robust  
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Figure 16. Pkp3 depletion results in permanent kinked axes due to prolonged 
entrapment in Vitelline membrane.  
 
(A) MO 1 or 3 injected embryos that survive hatching have permanently kinked 
axes (subpanels b and c, respectively) (40ng at one-cell stage). This is quantified 
in subpanel d, where the P-values indicate statistical significance. (B) The kinked 
phenotype of embryos injected with MO 1 or MO3 was significantly rescued upon 
manual removal of the Vitelline membrane at neurula stage 19. Normally, the 
embryo hatches later through the Vitelline membrane, at stages 33/34. 40ng of 
each morpholino was injected at the one-cell stage. P-value indicates statistical 
significance. 
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Figure 17. Pkp3 depletion results in tactile hyposensitivity. 
 
Further observation revealed that Pkp3 depleted embryos were non-responsive 
to gentle tactile stimuli as observed by light shaking of their incubation dish, while 
controls attempted to escape from such stimuli. Upon more pronounced 
stimulation, it became evident that the embryos were able to swim normally, 
indicating retained muscle function (etc.) (data not shown).  
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Figure 18.  Pkp3 depletion does not appear to affect early muscle formation.  
 
(A)  Following injection with either standard control morpholino or a mix of MOs 1 
and 3, the somites, an early muscle structure, do not appear disrupted. Note, the 
Pkp3 depleted embryo is laterally bowed towards the viewer, giving the false 
impression of compression of the somites. The number of somite segments was 
counted and compared, with no statistically significant differences found. 40ng of 
each morpholino was injected at the one-cell stage. (B)  Sectioning and 
histological staining of Pkp3 knockdown embryos reveals no defects in main 
body somites (subpanel b, SC embryo image obtained from second series of 
sectioning and staining). However, defects in the head regions were observed in 
some cases.  While possibly arising during sectioning due to reduced tissue 
integrity, there appeared to be overlaps in some embryos of the notochord and 
neural tube, as well as eye defects (subpanels d and e). NT, neural tube; NO, 
notochord; SO, somite. 
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mechanical stimulation, such as from firm prodding with a pipette tip (data not 
shown). Sectioning followed by H&E staining revealed that somites appeared 
grossly normal and oriented properly (Figure 18 and data not shown). It should 
be noted that the knockdown embryos were generally more fragile in head 
regions during sectioning procedures, with neighboring tissues not remaining as 
closely associated. Likewise, while possibly arising during sectioning, the 
boundary between the notochord and neural tube was altered in a proportion of 
Pkp3 depleted embryos (Figure 18 subpanel d). 
 
 To examine potential effects of Pkp3 depletion on neural structures 
that conceivably would influence embryo touch-responsiveness or the execution 
of embryo hatching, I used an antibody commonly used to mark differentiated 
neurons (directed against acetylated alpha-tubulin). While bundled motor 
neurons running within the inter-somitic regions appear unaffected by either MO1 
or MO3 (Figure 19), I observed a loss of fine neural structures in the most 
posterior regions of early tailbud embryos (Figure 15). Additionally, I observed 
the consistent diminution in length of a lateral neural tract within tadpole stage 
embryos, which failed to extend into the tail region as far as those of SC injected 
controls (Figure 20 and Figure 21). Such altered neuronal morphologies may 
conceivably interfere with transducing or processing stimuli, possibly including 
neuro-muscular outputs to enable swimming or embryo hatching. Alternatively, or 
in addition, even small perturbations of the ectoderm may disrupt relationships  
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Figure 19. Pkp3 depletion does not significantly affect motorneurites along the 
somite boundaries. 
 
Through the use of an established neural marker (acetylated alpha tubulin), 
examination of motoneurites arranged at somite boundaries revealed no large 
differences between controls and Pkp3 depleted embryos.  
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Figure 20. Pkp3 depletion results in late developmental neural defects. 
 
Neural processes present in the tadpole stage lateral neural tract that contribute 
to the sensory network, were reproducibly found to be foreshortened following 
Pkp3 depletion. Morpholinos (40ng each) were injected at the one-cell stage. 
 
SC 
MO 
MOs 
1&3 
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Figure 21.  Pkp3 knockdown significantly affects certain peripheral neural 
structures.  
 
Neural processes present in the posterior region (tailbud) of control tailbud stage 
embryos were reproducibly found to be less apparent and/ or foreshortened 
following Pkp3 depletion. Quantification of these results is shown here, where P-
values indicate statistical significance. 40ng of each morpholino was injected at 
the one-cell stage. 
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between mechanosensory and signal transducing cells, thus having an impact 
upon responses such as touch. 
 
Pkp3 may have a role in neural crest cell induction and migration  
 
To assess the impact of Pkp3 depletion within the prospective neuro-
ectoderm, especially given Pkp3’s expression pattern as reflected in Figures 6 
and 7 morpholino injections were made into a single dorsal blastomere at the 4-
cell stage, with rhodamine dextran coinjected as a lineage tracer. At tadpole 
stages, these embryos exhibited reduced eye size (subpanels b and c of Figure 
22). In embryos injected at the one-cell stage and later analyzed via sectioning, 
large segments of the eye were similarly found to be malformed (Figure 18B 
subpanel e). Also seen in embryo whole mounts (Figure 22), was a notable 
reduction in pigment cells throughout the embryo. As pigment cells are a neural 
crest derivative, Pkp3’s possible contribution to neural crest was suggested. I 
thus tested an established marker of neural crest in embryos depleted of Pkp3 
(versus SC injected). At early and late neurula stages (stages 16 versus 21; 
Figure 23), reporting respectively on inductive and migratory processes, the 
depletion of Pkp3 significantly reduced expression of Twist. FoxD3, another 
established neural crest marker, likewise exhibited disrupted expression at late 
neurula stages in response to Pkp3 depletion. Suggesting the specificity of these 
observations, we partially rescued the expression of both neural crest markers 
upon coinjection of exogenous Pkp3 (mRNA lacking the morpholino binding site; 
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Figure 24), but not with coinjection of exogenous beta-galactosidase. Based 
upon the pigment-loss and peripheral nervous system phenotypes, as well as the 
initial marker analysis, it appears that Pkp3 may contribute to forming at least 
some neural crest derived tissues. As additional tissues likewise depend upon 
the neural crest, future work will examine effects upon the craniofacial skeleton 
as well as the heart outflow tract. 
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Figure 22.  Neural crest derived tissues are disrupted upon Pkp3 depletion.  
 
Embryos injected with either MO 1 or 3 resulted in loss of pigmentation and 
reduced eye size (panels b and c) compared to negative controls (panel a). 40ng 
of either morpholino was injected at the one-cell stage. Percent of embryos with 
reduced pigmentation is quantitated in panel d. p-values were obtained through 
Student’s T-test. 
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Figure 23. Neural crest induction and migration is disrupted upon Pkp3 
depletion.  
 
In situ hybridization of the neural crest marker, Twist, following morpholino 
injection (20ng total MO into a single dorsal blastomere at the four-cell stage). At 
neurula stage 16, early (inductive) neural crest expression of Twist is reduced or 
lost (subpanel b vs subpanel a). At neurula stage 21, later (migratory) neural 
crest expression likewise appears affected, as the tracts in Pkp3 depleted 
embryos do not extend (subpanel d-e) in the normal pattern (subpanel c).  
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Figure 24. Expression of neural crest markers Twist and Foxd3 is affected by 
Pkp3 knockdown, but can be rescued by exogenous Pkp3 mRNA not targeted by 
Pkp3 morpholinos further indicating specificity of morpholinos. 
 
Expression of the neural crest markers, Twist and FoxD3, was analyzed by in 
situ hybridization following knockdown of Pkp3. Pkp3 morphants showed 
reductions of both markers in the neural crest domain, that could be partially 
rescued upon co-injection of exogenous Pkp3 lacking the morpholino targeted 
sequence(s). 20ng of each morpholino and 100pg of either Myc-tagged beta-
galactosidase or Myc-tagged Pkp3 mRNA was injected in a single dorsal 
blastomere. Quantification of these results is represented in the accompanying 
bar graph, where P-values indicate statistical significance.  
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Part Three: Identification of the Pkp3-catenin:ETV1 Complex 
 
Yeast two-hybrid screening identifies a novel Pkp3-associated protein 
 
Given the strong nuclear localization of Xenopus laevis Pkp3 in naïve 
ectoderm (“animal cap”) cells, and Pkp3’s suggested functional roles in Xenopus 
neural development (Figures 9, 15 and 22-24), we aimed to identify novel nuclear 
binding partners of Pkp3 involved in neural development. Employing Xenopus 
laevis Pkp3 as bait, we performed a yeast two-hybrid screen using an adult 
mouse brain cDNA library (Hybrigenics, Inc.). 351 clones were obtained, 
representing 156 distinct potential interactions. This screen suggested the Pkp3 
has roles in varied cellular compartments, with potential binding partners 
suggesting roles in cell shape, intracellular trafficking, small GTPase regulation, 
the cell cycle, RNA processing and transcriptional regulation.  
Included among the transcriptional regulators were ETV1 and ETV5, members of 
the large DNA-binding Ets-family, both falling within the much smaller (3-
member) PEA3 sub-family. Clones of ETV1 and ETV5 identified in the screen 
suggested that homologous regions interact with Pkp3, namely a region just 
proximal to and partially including the Ets/DNA binding domain (Figure 25). I 
chose to validate the Pkp3:ETV1 interaction, due to shared spatial expression in 
Xenopus (see Figures 6 and 7 reference [136]), and their common roles in neural 
development [120,137,138]. Our yeast two-hybrid screen of mouse brain was not 
saturating as desmosomal cadherins, desmocollin and desmoglein, and  
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Figure 25.  ETV1 and ETV5 are potential novel binding partners of Pkp3-catenin 
identified via yeast-two-hybrid.  
 
Schematics of ETV1 and ETV5 protein structures identified from yeast-two hybrid 
screen. Red line indicates the binding region as suggested by sequenced prey 
clones. 
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previously identified RNA binding partners were not isolated 
[16,17,28,45,84,88,99]. This is likely due to the absence or low expression of 
desmosomal components in neural structures following neurulation [139]. 
Interestingly, β2-spectrin, an ARVCF-catenin binding protein [140], was a strong 
candidate for interaction with Pkp3. This overlap may indicate a potential 
overlapping function between these and possibly other catenins, requiring further 
investigation. Given this potential overlapping binding partner and the homology 
between Pkp3 and ARVCF, especially in the armadillo repeats, ARVCF is an 
appropriate control to investigate binding partners that specifically interact with 
Pkp3, but not other catenin family members. In all cases, a homologous region of 
two closely related but independent members of the PEA3 subgroup of Ets-family 
transcription factors were implicated to associate with Pkp3-catenin. 
 
ETV1 interacts with Pkp3 in cells 
 
I first sought to confirm the Pkp3:ETV1 interaction using exogenously 
expressed Xenopus proteins. Antibodies are not available to precipitate 
endogenous Xenopus Pkp3 or ETV1, so HA-tagged xPkp3 (or negative control 
xARVCF) was coexpressed with Myc-tagged xETV1 in mamalian HEK 293T 
cells. HEK 293Ts cells provide the advantage of lacking detectable endogenous 
Pkp3 or ETV1 which could compete for exogenous interactions. In agreement 
with our yeast two-hybrid screen immuno-precipitation of HA-xPkp3 indicated 
that it interacts with Myc-xETV1, as did the reverse immuno-precipitation of Myc-
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xETV1 (Figure 26A). Suggesting the specificity of the Pkp3:ETV1 interaction, 
ARVCF-catenin, which is structurally related to Pkp3-catenin (e.g. both contain a 
prominent Armadillo-domain), did not or only very weakly associated with Myc-
xETV1. To test the conservation of the interaction across vertebrate species 
(Xenopus versus mouse), to confirm an endogenous interaction in a more 
developmental context, and confirm that Pkp3 and ETV1 interact in the nucleus I 
turned to the use of mouse embryonic stem cells (mESCs). mESCs exhibit easily 
detectible Pkp3 and ETV1 expression (Figure 26B), and we observed Pkp3’s 
prominent presence in the nucleus (Figure 27), which was also observed when 
Pkp3 and ETV1 were over expressed in HeLa cells (Figure 28). Importantly, co-
immunoprecipitation assays from nuclear lysates in this endogenous context 
further indicated that Pkp3 associates robustly with ETV1 (Figure 26B), whereas 
IgG control precipitations failed to resolve co-associations as expected.  
 
Interaction domain mapping of the Pkp3:ETV1 complex 
 
To investigate the interacting domain(s) of ETV1 with Pkp3, deletion 
constructs of ETV1 were utilized in conjunction with mitochondrial outer 
membrane (MOM) targeted Pkp3. The MOM localization domain of Bcl-XL was 
carboxy-terminally fused to either xARVCF-catenin or xPkp3-catenin, as 
previously undertaken for p120-catenin [140]. These fusion proteins localize to 
the MOM in a punctate pattern when expressed in HeLa cells, which were used  
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Figure 26. ETV1 and Pkp3 interact in cells. 
 
(A) Either HA-Pkp3 or HA-ARVCF was co-transfected with Myc-ETV1 in HEK 
293T cells. Anti-Myc (ETV1) or –HA (Pkp3 or ARVCF) immune-precipitates were 
subjected to immuno-blotting with anti-Myc (ETV1) and –HA (Pkp3 or ARVCF) 
antibodies. Pkp3-catenin co-precipitates ETV1, but the structurally homologous 
ARVCF-catenin does not (negative/ specificity control). ETV1 co-precipitates 
Pkp3, but does not co-precipitate ARVCF.  (B) Untreated AB-1 wild type mouse 
embryonic stem cells were lysed at 90% confluency and endogenous Pkp3 or 
ETV1 was immuno-precipitated, followed by immuno-blotting for Pkp3 and ETV1. 
Five percent inputs were acquired separately due to the low levels of 
endogenous proteins.   
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Figure 27.  Pkp3 localizes to nuclei of mouse embryonic stem cells.  
 
Mouse embryonic stem cells were fractionated into cytoplasm and nuclear pools, 
followed by immuno-blotting as indicated. Pkp3 fractionates to both the 
cytoplasmic and nuclear compartments. HeLa whole-cell extract was employed 
as a positive control. Fractionation efficiency of mouse embryonic stem cells was 
monitored via immuno-blotting for alpha-tubulin (cytoplasmic marker), or for lamin 
A/C (nuclear marker) (mouse embryonic stem cells exhibit low lamin A/C 
immuno-blot reactivity as compared to HeLa cells). 
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Figure 28.  ETV1 overexpression promotes Pkp3 nuclear localization 
 
HeLa cells were transfected with Pkp3-HA alone (top row) or Pkp3-HA with 
ETV1-MT (bottom row) and immune-stained for their respective epitope tag. 
Pkp3 transfection alone, causes little if any exogenous Pkp3 to enter the nucleus. 
However, when ETV1 is coexpressed with Pkp3 significant amounts of Pkp3 
enter the nucleus.
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for their ease of visualization (Figure 29; similar results were obtained using HEK 
293T cells; data not shown). Four xETV1 deletion constructs expressed at similar 
levels were tested for interaction with xPkp3-MOM (Figure 30A and data not 
shown). While the relocalized Myc-ETV1 fluorescent signals were faint, I 
reproducibly found that full-length ETV1 relocalized in small part to the MOM 
when co-expressed with xPkp3-MOM, but demonstrating specificity, not when 
co-expressed with the structurally homologus xARVCF-MOM (Figure 29Aa’ 
versus 30Af’ and 30C) . Our yeast two-hybrid analysis had suggested that a 
proximal part of the ETS domain, plus an inhibitory region immediately upstream 
in the protein sequence, was necessary for the xPkp3:xETV1 interaction. 
Deletion of this region (and more) in ETV1 (Figure 30Ab and 30Ac; CT-ETV1 and 
ΔY2H-ETV1, respectively, and 30C), abolished xETV1’s recruitment to xPkp3-
MOM. (Even as its general distribution led to the appearance of an overlap, close 
examination of CT-ETV1 showed that its signal was lost at sites of Pkp3-MOM 
relative to immediately adjacent areas). Interestingly, deletion of the ETS domain 
and C-terminus of ETV1 has no effect on ETV1’s ability to relocalize with xPkp3-
MOM. Consistent with suggestions from our initial yeast two-hybrid screen, these 
data point to a xETV1 region necessary for interaction with xPkp3 that include 
the proposed inhibitory domain (amino acid residues 257-335). 
  
Additionally, using an ETV1-MOM construct, I demonstrate that the amino-
terminus of Pkp3 is sufficient for interacting with ETV1 (Figure 31). However, 
while there is no strong relocalization of Pkp3’s ARM domain in this assay, there  
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Figure 29. Ectopic mitochondrial outer membrane (MOM) localization of Pkp3.  
 
Ectopic mitochondrial outer membrane (MOM) localization of Pkp3 was achieved 
by fusing a peptide sequence tag derived from human Bcl-Xl [140], that directs 
the fusion product (HA-xPkp3-MOM) to the MOM, producing a distinctive 
punctate pattern surrounding the nucleus that is characteristic of mitochondrial 
localization (right panel). An HA-Pkp3 construct lacking a MOM fusion tag (left 
panel), shows an entirely different localization pattern (cell-cell junctions, 
cytoplasmic and nuclear presence). All transfected cells observed demonstrated 
this patterning. 
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Figure 30.  Ectopic mitochondrial outer membrane (MOM) co-recruitment of 
xPkp3 with xETV1 in HeLa cells and ETV1 binding domain mapping. 
 
 (A) Co-expression of Myc-xETV1 or Myc-CoREST (negative/ specificity-control 
transcription factor) with MOM-targeted HA-xPkp3 or MOM-targeted HA-xARVCF 
(negative/ specificity-control catenin). Cells were co-immunostained for the 
ectopic co-relocalization of xETV1 (Myc-epitope, left panels), as well as for the 
MOM-targeted catenin (HA-epitope, middle panels). Ectopic co-relocalization of 
xETV1 with MOM-targeted xPkp3 was only observed when amino acids 257-335 
of xETV1 were present.  Representative images from a minimum of sixty cells 
expressing both constructs analyzed are shown.  (B)  List of Myc-tagged (MT) 
xETV1 constructs, and their interaction status with MOM-targeted HA-xPkp3. A 
positive score (+) indicates that >75% of cells coexpressing the indicated xETV1 
deletion construct showed co-relocalization of xETV1 with the MOM-targeted HA-
xPkp3 construct. Our prior laboratory studies have shown that authentic partner 
proteins re-localize to the MOM (fusion protein), as visualized by their increased 
signal at the mitochondria [140].  (C)  Quantification of cells processed for co-
relocalization of indicated xETV1 deletion construct with the MOM-targeted HA-
xPkp3 construct. 
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Figure 31.  Ectopic mitochondrial outer membrane (MOM) co-recruitment of 
xETV1 with xPkp3 in HeLa cells and Pkp3 binding domain mapping. 
 
 (A) Co-expression of HA-Pkp3 with MOM-targeted Myc-ETV1. Cells were co-
immunostained for the ectopic co-relocalization of MOM-targeted xETV1 (Myc-
epitope, left panels), as well as for the Pkp3 fragment (HA-epitope, middle 
panels). Ectopic co-relocalization of xPkp3 with MOM-targeted xETV1 was 
observed when amino acids 1-325 of xPkp3 were present.  Representative 
images from a minimum of sixty cells expressing both constructs analyzed are 
shown.  (B)  List of HA-tagged (HA) xPkp3 constructs, and their interaction status 
with MOM-targeted MT-ETV1. A positive score (+) indicates that >60% of cells 
coexpressing the indicated xPkp3 deletion construct showed co-relocalization of 
xPkp3 with the MOM-targeted MT-ETV1 construct. Our prior laboratory studies 
have shown that authentic partner proteins re-localize to the MOM (fusion 
protein), as visualized by their increased signal at the mitochondria [140].  
71 
 
is also no loss of its signal at the mitochondria making it unclear if any interaction 
exists between these molecules. 
 
xETV1 partially rescues molecular phenotypes resulting from xPkp3 
depletion in Xenopus embryos. 
 
As shown earlier the morpholino-directed depletion of Pkp3 (>60% 
efficiency as shown in Figure 10B) in early Xenopus laevis embryos results in 
altered neural crest establishment, as well as ectodermal fragility, touch 
hyposensitivity and heart defects. Additionally, it has been reported that ETV1 
localizes to neural crest cells during development and that other PEA3-subfamily 
members have roles in crest formation [136,141]. To test for an in vivo functional 
interaction between xPkp3 and xETV1, I attempted to rescue knock-down 
phenotypes following xPkp3 depletion through the exogenous expression of 
xETV1. Given the neural crest defects associated with Pkp3-catenin knockdown 
(Figure 24), we focused upon markers of neural crest establishment, namely 
Twist and FoxD3 (Figure 32). As shown in Figure 32B and 32C, xPkp3 depletion 
resulted in a reduction in Twist and FoxD3 expression. This xPkp3 depletion 
effect was significantly rescued upon the coordinate ectopic expression of 
xETV1. In agreement with findings presented below that were obtained using 
mammalian cell lines, these results are consistent with xPkp3 and xETV1 
interacting positively at the functional level in vivo (embryos), in keeping with their 
noted biochemical association.  
72 
 
 
 
 
A 
B C 
73 
 
Figure 32.  Rescue of neural crest establishment defects, induced upon xPkp3-
catenin depletion, through ectopic expression of xETV1.   
 
(A) The indicated morpholinos (20ng) and mRNAs (0.5ng) were co-injected into 
one dorsal blastomere at the four-cell stage with rhodamine dextran as a lineage 
tracer. After in situ hybridization for neural crest markers, Twist and FoxD3, 
embryos were imaged. The ectopic expression of ETV1-Myc largely rescued 
Twist and FoxD3 expression in embryos depleted for Pkp3-catenin (compare 
right-most images to middle images).  (B) Quantification of embryos processed 
for Twist in situ hybrization, comparing the uninjected side to the injected side for 
reduction in signal.  (C) Quantification of embryos processed for FoxD3 in situ 
hybrization, comparing the uninjected side to the injected side for reduction in 
signal. P-values indicate statistical significance. 
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Pkp3 positively modulates ETV1-dependent transcriptional activation 
 
Based upon the in vivo rescuing activity of ETV1 following Pkp3 depletion 
(see above), I expected that ETV1 and Pkp3 might positively interact to regulate 
gene activity. I first addressed this possibility using an established artificial ETV1 
reporter plasmid containing a fes gene promoter fragment encoding the ETV1 
consensus sequence (CAGGAAAG), repeated in triplicate (Fes3xWT-Luc) [142-
144]. As shown in Figure 33A, xPkp3 transfection alone resulted in a subtle effect 
upon the reporter (compare bars 1&2). This effect is significant (p<0.05), 
however, and might result from xPkp3 binding to endogenous (even if 
undetectable in immuno-blots) ETV1 associated with the Fes3xWT-Luc reporter.  
More obvious is xPkp3’s positive impact when exogenous ETV1 is co-expressed 
(compare bars 3&4). A less obvious, but still statistically significant effect 
(p=0.005), was reproducibly observed when assessing an independent natural 
reporter of ETV1 activity, employing the control element of matrix 
metalloproteinase-1 (MMP1-Luc; Figure 33B). When the primary ETV1 binding 
site in MMP1-Luc is mutated to reduce ETV1 binding (in Figure 33B, compare 
bar 3 from the wild-type promoter to bar 3 in Figure 33C from the mutant 
promoter; note Figures 33B and 33C were performed in parallel, but presented 
graphically separate for ease of readership), xPkp3 no longer induced promoter 
activity by itself (Figure 33C, compare bars 1&2), and only weakly enhanced an 
already weak ETV1 activation (compare bars 3&4). This suggests that xPkp3’s 
effects are dependent on ETV1 binding to the promoter and possibly that minimal  
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Figure 33. Pkp3-catenin regulation of ETV1 reporters.  
 
HEK 293T cells were transfected with expression plasmids for Myc-xETV1 or 
HA-xPkp3 in the indicated combinations.  (A) Pkp3’s functional relationship with 
ETV1 was tested using an established luciferase reporter for Ets family member 
transcriptional activity  harboring a  fes gene promoter fragment in triplicate 
(Fes3xWT-Luc,[143]). (B) Pkp3’s functional relationship with ETV1 was tested 
using a second established ETV1 reporter construct harboring a native matrix 
metalloproteinase-1 (MMP1) promoter fragment (MMP1-Luc,[142,145,146]). (C) 
MMP1(-87/-88)-Luc is a negative-control construct containing a non-functional 
ETV1  consensus binding site. Preformed in parallel to Figure 30B. P-values 
indicate statistical significance.  
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reporter activation upon xPkp3 transfection alone arises due to the presence of 
low levels of endogenous ETV1.  
 
Next, I evaluated the impact of xPkp3 upon endogenous ETV1 target 
genes [123]. As shown in Figure 34, xPkp3 knockdown in Xenopus embryos 
significantly reduced expression of established ETV1 targets involved in the 
dopamine transport and synthesis pathways, including dopa decarboxylase 
(DDC), tyrosine hydroxylase (TH), solute carrier family 18 member 2 (SLC18A2), 
and GTP cyclohydrolase I (GCH). These effects could be partially rescued upon 
the coordinate expression of ectopic ETV1. These findings continue to be 
consistent with the existence of a Pkp3:ETV1 functional interaction and Pkp3 
being a positive modulator of ETV1 in vivo. 
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Figure 34. Pkp3-catenin regulation of ETV1 target genes in vivo. 
 
The indicated morpholinos (40ng) and mRNAs (0.5ng) were injected into one-cell 
(cleavage) stage Xenopus embryos followed by RNA extraction at late neurula 
stages, DNAse treatment, reverse transcription, and real-time PCR to assess 
Pkp3- depletion effects upon ETV1 target-gene transcription. The co-injection of 
ETV1 mRNA with Pkp3 morpholino (MO) significantly rescued the impact of 
Pkp3-catenin depletion. The ETV1 gene targets assessed are each components 
of the dopamine synthesis and transport pathways and include: DDC = dopa 
decarboxylase; TH = tyrosine hydroxylase; SLC = solute carrier family 18 
member 2; and GCH = GTP cyclohydrolase I. All real-time PCR was repeated 
more than three times with samples tested in triplicate with similar outcomes. 
Error bars represent the standard deviation from three independent experiments. 
Differences between negative control (SC MO + β-gal) and Pkp3 knockdown 
(Pkp3 MO1 + β-gal) are all statistically significant based on the Student’s T-Test, 
demonstrating p-values < 0.05. Differences between Pkp3 knockdown (Pkp3 
MO1 + β-gal) and its rescue with ectopic ETV1 (Pkp3 MO1 + ETV1) are all 
statistically significant based on the Student’s T-Test, demonstrating p-values < 
0.05. 
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Chapter III 
 
Discussion 
81 
 
 In my study, I have evaluated the expression, subcellular localization, 
developmental roles and association of Pkp3 with ETV1. My work is the first to 
show Pkp3 is necessary for amphibian development, with depletions resulting in 
reductions of ectodermal integrity and heart defects, most likely from a reduction 
in desmosome number. Additionally, I find that xPkp3 plays important roles in 
neural crest development, with depletions causing various neurological defects of 
the peripheral nervous system. Distinct from reported protein interactions of Pkps 
at desmosomes, in stress granules and bound to single-strand DNA, I identified 
the first sequence-specific DNA binding partner of a Pkp, known as ETV1. ETV1 
is an Ets-family transcription factor, involved in various aspects of neural 
development and maintenance. I observe that this biochemical interaction is 
functionally relevant (based upon rescue analysis) to embyonic neural 
development in amphibians. My results form an initial outline of Pkp3’s role in 
amphibian development as well as revealing the first transcription factor to bind a 
Pkp.  
 
Pkp3 isoforms, expression and subcellular localization 
 
 I observed that Pkp3 mRNA levels increase in Xenopus following 
gastrulation, congruent with available sequence-tag data from mice 
(http://www.ncbi.nlm.nih.gov/UniGene/ESTProfileViewer.cgi?uglist=Mm.350037). 
Expression of a 75 kDa Pkp3 protein isoform coincides with this mRNA profile 
and further the protein persists in the adult frog. Presumably due to maternal 
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protein deposits made to the oocyte and passed onwards to the egg and embryo, 
I did not observe Pkp3 protein levels drop immediately following morpholino 
injection (data not shown). At such early stages (prior to gastrulation), I resolved 
a Pkp3 protein isoform migrating at 110 kDa, with a reduction in expression 
following gastrulation, and no detectable presence in adult tissues. This 
complementary expression of the Pkp3 protein isoforms leaves open the 
possibility of a switch in function between the two isoforms in early versus later 
embryonic development. The two isoforms of Pkp3 might originate from 
alternative translation initiation sites, as is well known to occur for p120-catenin 
[19,128]. Alternatively, while speculative, a conserved, potential caspase-3 site in 
Pkp3, which would produce ~75 and ~ 35 kDa fragments, may make it sensitive 
to caspase-3 (or other) cleavage, as we recently revealed for delta-catenin [147]. 
As was shown for delta-catenin, we would expect that this potential cleavage 
would result in fragments with differing functions and/or localizations. Whole-
mount in situ and immunoblot analyses indicate that Pkp3 is present in the skin 
and lungs of Xenopus and absent from the liver, consistent with previous 
expression data obtained from mouse tissues and mammalian cell lines 
[55,79,93,99,103]. However, distinct from prior reports, we further observe Pkp3 
localization in neural derivatives, heart, kidney and muscle, but not in the 
intestine or stomach. Interestingly, certain structures of the central nervous 
system and the peripheral nerves are connected to surrounding sheaths of 
epitheloid cells via desmosome structures [148], providing a potential function for 
Pkp3 in these tissues. However, I show Pkp3 to be acting outside the 
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desmosome in conjunction with ETV1 in the development of these tissues. 
Interestingly, the closely related p120-catenin subfamily has been shown to have 
widespread expression in adult Xenopus tissues [34,131,132]. The more 
restricted although partially overlapping expression profile of Pkp3 suggests that 
it might fulfill specialized functions.    
 
At the intracellular level in both Xenopus and mouse embryonic stem cells, 
Pkp3 localizes to a number of cell compartments including the nucleus, which 
had previously been ascribed as potentially exceptional or artifactual in 
mammalian systems [45]. However, my findings regarding Pkp3 are based upon 
both endogenous and exogenous detection, and coincide with detailed 
descriptions of nuclear Pkp1 and Pkp2, as well as of multiple other catenin family 
members [92,94,95,147,149]. Indeed, we have preliminarily resolved a number of 
nuclear proteins in association with Pkp3 that are now being characterized (data 
not shown) in addition to my confirmed interaction with ETV1. One possibility for 
the prior discrepancies, while requiring further investigation, may be explained 
through closer examinations of nuclear Pkp3 in Xenopus animal cap cells 
(Xenopus embryonic stem cells), and mouse embryonic stem cells. As the 
nuclear localization of Pkp3 is not readily discernible in adult mammalian tissues, 
the nuclear localization in these stem cell lineages may be transient. This would 
suggest a significance in early development that decreases as the animal 
matures and certain nuclear functions are possibly no longer required. I expect 
that plasma membrane-associated Pkp3 in Xenopus contributes to desmosome 
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formation and/or stability, as has been well characterized in mammalian systems 
[45,78,93,99,102]. In conjunction with Pkp3’s structural capacity at desmosomes, 
the presence of Pkp3 at desmosomal junctions, and in the cytoplasm and 
nucleus, provides the possibility that this catenin may assist in a signaling 
capacity in cross-talk between junctional, cytoplasmic and nuclear 
compartments. These signaling roles might, for example, include Wnt signaling 
and small GTPase modulation as has been shown for other catenins [48,150-
152].  
 
Developmental roles of Pkp3 
 
 Amphibian embryos have provided a number of instances where depletion 
of genes of interest generate more obvious phenotypes than does their 
corresponding knockout in mammals/ mice. This has been true for various 
catenins, with more pronounced developmental effects following either Xenopus 
ARVCF or delta-catenin knockdown than found in knockout mice [34,49,153] (R. 
Kucherlapati, personal communication). Therefore, to uncover potentially novel 
development roles of Pkp3 relative to what had been reported in the mouse, I 
took advantage of the experimental advantages of the amphibian system [154], 
using knockdown approaches in Xenopus laevis.  
 
To examine Pkp3 functions in vivo, I used Pkp3 sequence specific 
antisense morpholinos to block ribosome binding and translational initiation of the 
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Pkp3 transcript. This standard depletion approach, using either of two distinct 
sequence specific morpholinos, revealed a number of consistent phenotypic 
outcomes. Interestingly, in Pkp3 knockout mice, Pkps 1 and 2 were upregulated 
most likely as a compensatory mechanism [102], while in Xenopus, I found that 
Pkp3 depletion did not appear to alter Pkp2 mRNA or protein levels. Thus, this 
less pronounced compensation among Pkps in amphibians may allow for the 
more severe effects I observed following Pkp3 knockdown in Xenopus relative to 
losses of Pkp3 in mammals. 
 
In evaluating targeted tissues such as neural crest, where one dorsal cell 
within a 4-cell embryo was injected with morpholino, I supported the specificity of 
the Pkp3 depletion phenotype by using an add-back approach. We observed 
consistent if partial rescues through expression of morphlino-resistent Pkp3. Self-
rescues were more difficult to obtain in embryos injected with morpholinos at the 
1-cell stage (or both cells of a 2-cell embryo), since essentially the entire embryo 
must be coordinately rescued. To address this concern, I employed the standard 
in the field, reproducibly obtaining similar phenotypes using independent (non-
overlapping) morpholinos. 
 
MO 1, targeting a region upstream of the translational start site, exhibited 
the highest phenotypic and Pkp3-protein knockdown penetrance. Each 
morpholino caused skin fragility, heart deformation, tactile hyposensitivity and a 
delayed escape from the Vitelline membrane. Increased skin fragility was 
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correlated with a decrease in the number and size of basally disposed 
desmosomes within the outer ectoderm, phenocopying prior Pkp3 depletion 
studies, and studies of patients with Pkp1 mutations that exhibit skin fragility 
ectodermal-dysplasia [68,70,102,155]. Mutations or loss of desmosomal 
components, including Pkp2 but not the other Pkps, are known to compromise 
desmosome structure and lead to arrhythmogenic right ventricular dysplasia and 
heart failure in patients [73,75,156]. Our results in Xenopus likewise suggest that 
Pkp3 is needed for heart formation and/or maintenance in Xenopus, possibly 
participating in a desmosomal context similar to that of Pkp2 in human heart, 
and/ or conceivably as an indirect consequence of effects upon neural crest, 
which contributes to the heart outflow tract [157]. The effects of Xenopus Pkp3 
knockdown effects on ectoderm and desmosomes confirms the prior phenotypes 
identified in other models (Figure 35), but the impact upon heart is interesting, 
since reports from mouse and human have indicated that Pkp1 or 3 loss or 
mutation does not result in heart effects. It thus appears that this species 
distinction warrants future investigation. 
 
In addition to the noted heart phenotypes in Xenopus, Pkp3 depletion 
caused defects in the multiciliated cells of the ectoderm. In overexpression 
studies, a punctate Pkp3 localization was observed in the same apical region 
where cilia are organized within these cells, suggesting a novel role for Pkp3 in 
cilia establishment or maintenance. Interestingly, we have identified a number of 
intracellular trafficking and motor proteins that we have preliminarily  
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Figure 35. Potential molecular mechanisms regulating Pkp3 developmental 
functions in amphibians. 
 
Pkp3 is depicted with known or likely activities indicated, and how these activities 
are expected or conjectured to relate to observed developmental functions in 
Xenopus. I expect that Pkp3's desmosomal roles contribute to proper formation 
of the skin and heart in Xenopus. Additionally, the potential role of Pkp3 as 
suggested from other Pkps and p120-catenin subfamily members in the 
modulation of small GTPases or trafficking motor proteins, may underlie the 
Pkp3's observed roles in vesicle transport and/ or cilia formation. It must also be 
considered that the regulation of small-GTPases and trafficking motor proteins 
would affect neural development, given the significant contributions these 
pathways provide to neural cytoskeletal structures and vesicle transport. 
However, given that ETV1 expression significantly rescues loss of neural crest 
cells due to Pkp3 knockdown, I expect that a major developmental role of Pkp3 in 
neural tissues occurs through the Pkp3:ETV1 nuclear interaction I resolved. 
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identified in association with Pkp3. These proteins were found previously by 
others to participate in cilia formation, cilia activity, vesicle transport or 
mitochondrial localization (Figure 35 and data not shown). Consistent with 
potential Pkp3 contributions to vesicle transport and cilia formation, the 
structurally related Pkp2 was found in mammalian cells to affect kinesin 
dependent intracellular transport of Dsg2 along microtubules. Additional catenin 
family members (p0071-, p120- and ARVCF-catenin) have been shown to have 
roles in actin organization [41,49,50,52,54,158]. 
 
 We further uncovered an unexpected role for Pkp3 in amphibian sensitivity 
to tactile stimuli. The observed hyposensitivity that followed Pkp3 depletion can 
be partially attributed to the reduction or compromised function of certain sensory 
(and/ or motor?) neural tracts along the length of the animal, including the lateral 
tract that is responsible for transduction of tactile responses from the ectoderm to 
brain [159]. The requirement of Pkps in neural function has not been previously 
noted, and might prove to be an interesting area for future investigation. Tactile 
sensory pathways are mostly derived from neural crest cells [160,161], where we 
found indications that Pkp3 plays a necessary role. The neural crest molecular 
markers (Twist & FoxD3) and neural crest derived pigment cells were each 
notably reduced following Pkp3 depletion. Numerous signaling pathways, 
including the canonical and noncanonical Wnt pathways, act in neural crest cell 
specification and migration [160,162]. While speculative, since canonical Wnt 
signals are transduced by beta-catenin, recent evidence regarding the 
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involvement of vertebrate p120-catenin [152] supports that more distant 
members of the catenin family such as Pkp3 may additionally contribute to Wnt 
mediated processes in neural crest. Indeed, our preliminary results suggest a 
stabilization of Pkp3 by positive Wnt pathway modulators (data not shown). 
Additionally, small GTPases and intracellular trafficking proteins play important 
roles in the differentiation and stability of neural tissues through their effects on 
cell shape and motility, and positioning of various molecules necessary for proper 
neural synapses, respectively. Thus, Pkp3’s potential regulation of these groups 
of proteins identified in our yeast-two-hybrid could also contribute to the observed 
phenotypes of Pkp3 depletions. 
  
Identification of the Pkp3:ETV1 interaction 
 
 Our yeast two-hybrid screen using full-length Pkp3 as bait revealed 
multiple potential binding partners, including several nuclear/ gene-regulatory 
proteins such as ETV1 and 5. The mouse brain cDNA library used in this screen 
was chosen because of my earlier observations of xPkp3’s possible roles in 
neural development [90], and because of the lack (or lower expression) of 
desmosomal components in brain that otherwise might dominate the screen and 
interfere with resolution of less obvious, but important nuclear interactions.  
 
I confirmed the Pkp3:ETV1 association in co-immunoprecipitation 
experiments involving both exogenous and endogenous proteins. In conjunction 
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with such co-immunoprecipitations, we showed that Pkp3 localizes to both the 
nucleus and cytoplasm of mouse embryonic stem cells, similar to our earlier 
observations of Pkp3 in Xenopus naïve ectoderm (“animal cap”) cells [90]. 
Additionally, the relocalization of Pkp3 to the nucleus when ETV1 is 
overexpressed, and the co-immunoprecipitation of endogenous proteins from 
purified nuclear lysates, show that this interaction is most likely occurring in the 
nucleus.  
 
The Pkp3:ETV1 interaction was further supported in functional assays, 
where ETV1 expression was able to significantly rescue the loss of neural crest 
markers that are otherwise diminished upon Pkp3 knockdown (Figure 35). 
Additionally, my data shows that Pkp3 can modulate ETV1 transcriptional 
activity, as measured by both reporter gene assays and endogenous gene 
expression. Based upon depletion and rescue analyses, Pkp3 acts positively at 
known dopaminergic ETV1 target genes. As the dopaminergic neurons are 
necessary for somatosensory responses [163], this relationship might account for 
the earlier phenotypic effects I observed in developing Xenopus embryos, where 
Pkp3 depletion led to clear perturbations of sensory neural tracts and to the 
reduction of responsiveness of early and tailbud stage embryos to touch [90]. 
 
 With respect to the reporter assays, Pkp3's positive effect when co-
expressed with ETV1 was obvious when using the artifical (3x) Fes Ets-binding 
element, while a more marginal but still significant effect arose using the natural 
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MMP-1 promoter fragment. Pkp3’s ability to activate the reporter on its own or in 
conjunction with exogenous ETV1 was largely eliminated upon mutation of the 
ETV1 consensus binding site. This suggests, as we would predict, that Pkp3's 
effects are dependent upon ETV1's direct association with DNA. Interestingly, 
Pkp3 appears to be a stronger inducer of the artificial (3x) Fes Ets-binding 
element reporter in a cell-free system, relative to ETV1. In this cell-free system, 
Pkp3 may promote the activity of the RNA Polymerase III complex as has been 
suggested for Pkp2 [97], a possibility that requires future studies. Regarding my 
analysis of endogenous gene expression, it is noteworthy that Pkp3 knockdown 
reduces expression of ETV1 targets, and that this can be rescued by expression 
of ectopic ETV1. 
 
 All of these results are consistent with the view that Pkp3 acts as a co-
activator in association with ETV1.  
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Concluding remarks 
 
My work indicates that Pkp3 is necessary for various aspects of amphibian 
development including ectoderm integrity, heart formation or maintenance, and 
neural development. While the ectoderm and heart contributions are significant, 
they have been previously characterized for the Pkps in general, which exhibit 
some inter-compensatory properties, and found to relate to desmosome 
formation and stability [68,70,73,75,102,155,156]. In contrast, the Pkp3 
contributions to neural development that I uncovered represent a novel area of 
Pkps’ biology, with Xenopus providing a way to investigate Pkp3’s functions that 
may otherwise be compensated for by Pkp1 or 2 in other species. Additionally, 
my work establishes ETV1 as the first nuclear binding partner of Pkp3, and to our 
knowledge, the first site-specific DNA-binding transcription factor binding to any 
of the plakophilin/ Pkp-catenins.  
 
 Xenopus Pkp3’s role in ectoderm integrity and desmosome size and 
number is consistent with previous reports showing that Pkp3 contributes to 
desmosome stability, with loss of Pkp function in humans leading to ectoderm 
fragility and arrhythmogenic right ventricular disease as a consequence of 
desmosomal defects [17,28,68,70,73,75,76,93,102,155,156,164]. While the 
desomosomal roles of Pkp’s have been reasonably well studied, their 
cytoplasmic and nuclear functions are poorly defined [17,18,40,41,88,89,92]. 
Individual catenins appear to have distinct interactions with transcription factors, 
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even as some interactions may be shared. For example, beta-catenin binds/ 
modulates the TCF/LEF transcriptional repressor, while p120-catenin binds/ 
modulates the Kaiso transcriptional repressor [57-59]. Intriguingly, some gene 
targets appear to be regulated coordinately by beta-catenin:TCF/LEF and p120-
catenin:Kaiso, with upstream canonical-Wnt signals regulating the nuclear 
activity of both beta-catenin and p120-catenin (isoform1) [62,65,152,165,166]. 
Recent evidence has suggested that Pkp1 and Pkp2 may have differing roles in 
the nucleus, with Pkp1 binding to single-stranded DNA and Pkp2 associating with 
RNA polymerase III [92,97]. I have yet to test if Pkp1 or 2 associates with ETV1 
(or ETV5), as reported here for Pkp3, though preliminary results suggest Pkp2 
may enhance ETV1 transcriptional activity as well (data not shown). In resolving 
Pkp3’s interaction with ETV1, we demonstrate for the first time to our knowledge 
that a Pkp-catenin functions in association with a site-specific DNA-binding 
transcription factor. In this regard, Pkp3's nuclear role(s) may be analogous in 
concept to those previously established for catenins of the beta- and p120-
subfamilies (Figure 36).  
 
Future work will be required to determine whether Pkp1 and Pkp2 also 
associate with ETV1, and thus potentially compensate in part for Pkp3 loss. 
Additionally, other potential Pkp3 binding partners identified in our screen will 
require further validation such as ETV5, with its strong similarity to ETV1, and 
HNRNPK, which is interesting because of its role in both transcription and 
translation possibly bridging the Pkp3 roles inside and outside the nucleus.  
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Figure 36. Transcriptional activity of various catenin family members. 
 
(A) When beta-catenin is not bound to the transcription factor TCF, TCF acts as 
a transcriptional repressor. Once beta-catenin is bound to TCF, the complex 
promotes transcription. (B) p120-catenin de-represses (activates) Kaiso target 
genes by removing Kaiso from its target DNA sequence. (C) ETV1 activity is 
enhanced by the co-activator Pkp3.
97 
 
Future work will also address how Pkp3-catenin confers positive gene-regulatory 
effects in association with ETV1, possibly for example, through assisting with the 
recruitment of transcriptional co-activators such as shown for beta-catenin in 
association with TCF/ LEF (reviewed in Saito-Diaz et al., 2013 and Mosimann et 
al., 2009) [167,168]. To further test how Pkp3 confers this regulation, individual 
ChIP-seqs of Pkp3, ETV1 and various chromatin modifications should be 
performed. This would reveal regions bound by both Pkp3 and ETV1 while also 
revealing how the chromatin is being modified at these sites. RNA-seq performed 
in parallel, comparing the impact upon the transcriptome of varying levels of 
Pkp3 and ETV1 (perhaps additionally comparing forms of Pkp3 or ETV1 
incapable of binding the other), could also be used to help characterize genes 
regulated by the Pkp3:ETV1 association. I also demonstrated that an inhibitory 
region (amino acids 257-335), previously characterized in ETV1 and like-
members of the PEA3 Ets-subfamily [117,127,169], is required for Pkp3's 
association with ETV1. Work from others has shown that when this region is 
bound by an antibody, the DNA binding region is unmasked to more readily bind 
DNA [118]. We speculate that Pkp3 binding to ETV1 may act similarly, 
unmasking ETV1’s DNA binding domain and therefore promoting ETV1's 
transcriptional activity. In addition, I found that the amino-terminus of Pkp3 is 
required for ETV1 association. This region is known to be necessary for 
interaction with the desmosomal cadherins [20]. While requiring future 
investigation, the requirement for this same region of Pkp3, albeit in differing 
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cellular compartments (junctions versus nucleus), may result in competition 
between ETV1 and cadherins for Pkp3 binding.  
In addition, the possible pleiotropic effects of the Pkp3 knockdown must 
be addressed. This could be examined using transplantation experiments in 
Xenopus. Naïve ectoderm from negative control or Pkp3 depletion (or Pkp3 
expression, etc.) donor embryos ubiquitously expressing GFP would be tested 
for its ability to contribute to the various structures in host animals that were 
affected in my previous Pkp3 depletion studies. This would largely reduce 
concerns of Pkp3 manipulation of larger regions of the embryo producing 
secondary effects upon regions of interest. Of further use to more selectively 
define Pkp3's effects is to better map the regions of Pkp3 necessary for each 
molecular function, perhaps even extending to a co-crystal structure of 
Pkp3:ETV1. Point or other refined mutants of Pkp3 could then be devised to 
abrogate selected functions of Pkp3, to be used in add-back experiments where 
Pkp3 has been depleted (via MOs, etc.), generating host embryos for the above 
transplantation experiments. This would help to resolve how each Pkp3 
biochemical interaction relates to its developmental roles in vivo. For example, I 
expect that when a Pkp3 point mutant that no longer interacts with ETV1 is used 
in add-back experiments in donor embryos depleted for ETV1, the transplanted 
naïve ectoderm would no longer differentiate into neural crest or the peripheral 
nervous system.  
 
 In a more clinical regard, ETV1 has been shown to have a role in 
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regulating matrix metalloproteinases during tumorigenesis [125-127,170], and it 
may prove worthwhile to test ETV1 target gene expression in human patients 
with elevated Pkp3 levels [77,105]. Likewise, we anticipate that Pkp3 loss or gain 
might prove relevant in certain neurological contexts, given ETV1's established 
roles in the dopaminergic pathway (etc.) of differentiating neurons. 
 
Another question is how Pkp3 itself is regulated, and how such regulation 
would affect ETV1 activity. In conjunction with prior reports showing stabilization 
of the closely related p120-catenin sub-family members by Wnts, we have strong 
preliminary results that suggest Wnt signals likewise stabilize Pkp3 in Xenopus 
[65,152]. Once stabilized by Wnt signals, I speculate that the signaling pool of 
Pkp3 would be enhanced to interact with ETV1. This would then be expected to 
alter ETV1-modulated gene regulation and have an impact upon events, such as 
the specification of neural crest cells, and in later development, the differentiation 
of posterior neurons. Finally it would be of interest to examine the molecular 
differences between the Pkps across species to identify what may have given 
rise to the functional distinctions throughout evolution, especially given that a 
recent analysis of the Pkp-subfamily suggested that it evolved recently and 
rapidly [19].  
 
Overall, my study revealed novel developmental roles of Pkp3 and 
identified the first transcription factor to bind a Pkp, thus broadening our 
understanding of the Pkp-subfamily of proteins.  
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Chapter IV 
 
Materials and Methods 
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Embryo manipulations and Ethics 
 
Xenopus laevis embryos were obtained, fertilized and microinjected as 
previously described [171], except that microinjections were performed in 5% 
Ficoll in 0.3X MMR (Marc’s modified ringers solution), and cultured in solution for 
at least one hour. Embryos were then transferred to 0.3X MMR with 50 µg/mL 
Gentamycin for culture at 14-18°C. Phenotypes were visually scored at various 
embryonic stages using a standard binocular stereoscope (Olympus SZX12).  
 
This study was carried out in strict accordance with the recommendations 
in the American Association for Laboratory Animal Science Learning Library. The 
protocol was approved by the Institutional Animal Care and Use Committee of 
the The University of Texas-M.D. Anderson Cancer Center (ACUF Protocol #09-
93-05717). All efforts were made to minimize animal discomfort. 
 
Xenopus laevis Pkp3 cDNA isolation 
 
In collaboration with Kris Vleminckx a Pkp3-specific cDNA fragment from 
Xenopus laevis was identified via screening of a cDNA library (embryonic stage 
30; Stratagene), using a labeled human Pkp3 cDNA fragment. Further Pkp3 
sequence was obtained using 5' RACE of mRNA extracted from Xenopus laevis 
XTC cells, and the assembled clone entered into the pGEMTeasy vector.  
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Histological sections 
 
Histological sections were prepared by embedding embryos in paraplast 
using standard methods. Sections were then obtained at 10 µm thickness and 
stained with hematoxylin and eosin and mounted [172].  
 
Touch sensitivity assay 
 
Embryos from stage 26-45 were subjected to a tactile stimulus. Using 
either gentle displacement of the incubation dish or the light touch of a pipette tip, 
a mild physical stimulus was applied to the embryo and its reaction was 
observed. Control embryos at earlier stages are not very active, but when a 
tactile stimulus is applied they swim away from the stimulus.   
 
Electron Microscopy 
 
In collaboration with Malgorzata Kloc at Houston Methodist Hospital, 
embryos were fixed in 2% formaldehyde, 3% glutaraldehyde (EM grade from Ted 
Pella Inc., glutaraldehyde 8% stock, 18421; formaldehyde 16% stock, 18505) in 
1x phosphate buffered saline (PBS). 
 
For transmitted electron microscopy, samples were dehydrated in ethanol 
at increasing concentrations, infiltrated and embedded in LX-112 medium (Epon 
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substitute; Ladd Research Industries). Ultrathin sections (70-100 nm) were 
contrasted with uranyl acetate and lead citrate according to standard protocols 
[173]; the sections were then examined in a JEOL 100SX transmission electron 
microscope (JEM, Japan) at an accelerating voltage of 80 kV.  
 
For scanning electron microscopy, fixed samples were washed with 0.1 M 
cacodylate buffer, pH 7.3 for 3 x 10 min. The samples were then post fixed with 
1% cacodylate buffered osmium tetraoxide for 1 hour, washed with 0.1 M 
cacodylate buffer for 3 x 10 min, and then in distilled water, 2 x 5 min. The 
samples were sequentially treated with Millipore-filtered 1% aqueous tannic acid 
for 30 min in the dark, washed in distilled water 3 x 10 min, and then in Millipore-
filtered 1% aqueous uranyl acetate for 1 hour in the dark. Samples were rinsed 
with distilled water for 2 x 5 min, and were then dehydrated with a graded series 
of increasing concentrations of ethanol for 5 min each. The samples were 
transferred to graded series of increasing concentrations of hexamethyldisilazane 
(HMDS) for 5 min each and air dried overnight. Samples were mounted on 
double-stick carbon tabs (Ted Pella. Inc., Redding, CA), which had been 
previously mounted on aluminum specimen mounts (Electron Microscopy 
Sciences). The samples were then coated under vacuum using a Balzer MED 
010 evaporator (Technotrade International) with platinum alloy for a thickness of 
25 nm, and immediately flash carbon coated under vacuum. The samples were 
transferred to a desiccator for examination at a later date. Samples were 
examined in a JSM-5910 scanning electron microscope (JEOL USA, Inc.) at an 
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accelerating voltage of 5 kV. 
 
Antisense morpholinos 
 
Two independent Xenopus Pkp3 translation-blocking morpholinos (Pkp3 
MO 1 5’-CTCTCTCTCTGTCCCTGAGAGGCTT-3’ and Pkp3 MO 3 5’-
GCTTTAGTGTAGGCTCGGACCCCTC-3’), and a standard morpholino (5’-
CCTCTTACCTCAGTTACAATTTATA-3’) were obtained from Gene Tools.  
 
DNA constructs 
 
pCS2-HA(CT)/xPkp3, pCS2-HA(CT)/xPkp3+5’UTR, pCS2-myc/xPkp3 and 
xPkp3 fused to a Bcl-Xl MOM targeting sequence were made by PCR 
amplification of xPkp3 cDNA from pGEM11XLPKP3 and cloning into the pCS2 
vector with the indicated epitope tag. Xenopus ETV1 cDNA was purchased from 
Open Biosystems (Thermo Fisher Scientific) and cloned into pCS2-myc. ETV1 
fragments used for mapping of interactions with Pkp3 were cloned from pCS2-
myc/xETV1 into pCS2-myc. Subsequent production of in vitro transcribed RNAs 
was done using the mMESSAGE SP6 kit (Ambion), with capped mRNAs 
synthesized in vitro following Not1 linearization. Transcripts were then acidic-
phenol/chloroform extracted and unincorporated nucleotides were removed using 
Sephadex G-50 Quick Spin Columns (Roche). mRNA was ethanol precipitated at 
-80°C, and mRNA integrity then examined via agarose gel electrophoresis and 
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ethidium bromide staining. Other constructs were reported previously and kindly 
provided by Dr. L. Shemshedini (Fes3xWT-Luc and MMP1-Luc) and Dr. R. 
Janknecht (MMP1 -87/-88) [142,145,146]. 
 
RNA isolation and semi-quantitative real time PCR  
 
RNA isolation and semi-quantitative real time PCR were performed as 
previously described [90]. Briefly, total RNA was extracted from Xenopus 
embryos using Trizol (Invitrogen). DNA was removed with RQ1 DNase (Promega 
M610A). Constant amounts of total RNA were reverse-transcribed into cDNA 
pools using oligo-dT (Invitrogen 18418-012) and SuperScript III Reverse 
Transcriptase (Invitrogen 18080-044). cDNA was then used as template for 
either real time PCR with SYBR Green Master Mix or PCR amplification. To 
control for DNA contamination, reactions were performed in the absence of 
reverse transcriptase. PCR primers are as follows: DDC 5’-
TGGAGAGGGCTGGACTGATC-3’, DDC-R 5’-AGCCTGACCACGAGCTACAAA-
3’, TH-F 5’-GCCGGATTGTTGCCATGA-3’, TH-R 5’-
GGCCCCCAAAGATGCTAAAC-3’, SLC18A2-F 5’-GCCCCCCGCTATCAACTT-
3’, SLC18A2-R 5’-ACCTTCCGATTTTTTGTGCAA-3’, GCH-F 5’-
TCTGGTGTTGGAGTGGTTGTTG-3’, GCH-R 5’-
CCCCTAGCATGGTACTCGTTACA-3’, ARM-F 5’-
ATGGCATTTATGAACTGTTGACCGCTTT-3’, ARM-R 5’-
TCTGCGTGAGTGGGTTTAAGGTGTCC-3’, HH4-F 5’-
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CGGGATAACATTCAGGGTA-3’, HH4-R 5’-TCCATGGCGGTAACTGTC-3’, 
Pkp2-F 5’-TCGGCTGTTGCTCACATGATT-3’, Pkp2-R 5’-
ATTTCTCTCGCGATCTCATTTTGG-3’, ODC-F 5’-AAAAAGCATGTGCGTTGGT-
3’, ODC-R 5’-ACGGCATAAAACGGAGTGA-3’.  
. 
Whole-mount in situ RNA hybridization 
 
Whole-mount in situ RNA hybridizations were performed as previously 
described [154]. Briefly, digoxigenin-labeled sense and antisense RNA probes 
were prepared through in vitro transcription (DIG RNA Labeling Kit, Roche 
11175025910). Probes were detected with anti-digoxigenin antibody conjugated 
to alkaline phosphatase (Roche 11093274910), and NBT/BCIP (Roche 
11697471001) was used as a reaction substrate. Sections of stained embryos 
were obtained using previously described methods [174]. 
 
Immunostaining and fluorescent imaging of embryos 
 
Embryos were fixed in 1X MEM and 4% Formaldehyde at specified stages 
for 1-2 hours followed by dehydration in 100% methanol at -20oC overnight. 
Rehydration was done in 1X PBS with 0.1% Tween-20 (PTw) followed by 
blocking in 20% goat serum in PTw. Primary antibody (Myc 1:500; Pkp3 1:12.5; 
12/101 1:500; acetylated alpha tubulin 1:500) incubation was preformed 
overnight at 4oC in 10% goat serum in PTw. Samples were washed in PTw (5X 
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over 5 hours), and then incubated overnight with secondary antibody (Alexa-488 
or -555 conjugated to anti-rabbit or mouse specific antibody) in PTw, and washed 
again (5X over 5 hours). For experiments involving the detection of acetylated 
alpha-tubulin, 25-45 overlapping images were obtained per embryo sample using 
a Leica DM4000B, and then photomerged using Adobe Photoshop CS4. Sub-
cellular localization was assessed via confocal microscopy using an Olympus 
IX70 microscope and images analyzed with Fluoview 500 software. 
 
Yeast two-hybrid 
 
Full-length Xenopus Pkp3 was used to screen an adult mouse brain and 
human keratinocyte cDNA library in collaboration with Hybrigenics ULTImate 
Y2H [175]. We obtained 351 positive clones that were then sequenced and 
analyzed. We were attracted to two clones in particular, ETV1/ER81 and 
ETV5/ERM, given that they fall within the same PEA subgroup of Ets-family 
members, which are known to have wide ranging roles in transcriptional control 
[127,144,176]. 
 
Nuclear Fractionation, Immunoprecipitation, and Immunoblotting 
 
Nuclear fractionation of mouse embryonic stem cells required a 10 cm 
plate of AB-1 wild type cells at 80% confluency for 3 immuno-precipitating 
conditions. One plate of cells was collected by scraping, and then washed with 
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10 mL PBS and pelleted by centrifugation at 200xg for 2 minutes. The pellet was 
resuspended by gentle pipetting in 600 ul ice-cold buffer A (20 mM HEPES, pH 
7.9; 10 mM KCl; 0.2 mM EDTA; protease inhibitors). The cells were allowed to 
swell for 15 minutes on ice. Following, 37.5 ul of 10% NP-40 was added and the 
tube vortexed 10 seconds. Nuclei were collected by centrifugation at 200xg for 
10 minutes (supernatant contains cytoplasm, and the pellet contains nuclei). The 
nuclei were resuspended in 300 ul ice-cold buffer C1 (20 mM HEPES, ph 7.9; 
400 mM NaCl; 10 mM EDTA; 1 mM EGTA; protease inhibitors) and were rocked 
at 4oC for 1 hour, prior to centrifugation at 16,100xg (microfuge maximum speed) 
at 4oC for 10 minutes (supernatant contains the nuclear extract). For immuno-
precipitations, extracts were transferred to new tubes and diluted with one 
volume of ice-cold buffer C2 (20 mM HEPES, pH 7.9; 10 mM EDTA; 1 mM 
EGTA; protease inhibitors). One aliquot was set aside for whole nuclear lysate 
detection. Extract was diluted to a final volume of 1.5 mL with cold buffer C3 (20 
mM HEPES, ph 7.9; 200 mM NaCl; 10 mM EDTA; 1 mM EGTA; protease 
inhibitors).  
 
Protein A/G PLUS-Agarose (Santa Cruz Biotechnology SC-2003) (10 ul 
packed agarose/condition) was washed three times in cold buffer C3. After the 
last wash, the precipitating antibody was added to the beads (e.g. anti-Pkp3 
hybridoma supernatant 11F2 – 300uL; anti-ETV1 – 3ug; mouse IgG – 3ug) and 
was rocked 45 minutes at 4oC. The beads were centrifuged at 1,000xg for 2 
minutes and washed 3x with cold buffer C3 containing 0.5% Triton X-100. 
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Following agarose bead preparation and nuclear lysate dilutions, 500 uL of lysate 
was added to the beads and rocked gently for 1 hour at 4oC, centrifuged at 
1,000xg for 2 minutes, and washed 3x with cold wash buffer (20 mM HEPES, ph 
7.9; 200 mM NaCl; 10 mM EDTA; 1 mM EGTA; 0.5% Triton X-100; 0.5% sodium 
deoxycholate; 0.1% SDS). The final bead pellet was resuspend in 30 ul of 2x 
protein sample buffer and the entire sample loaded. Immunoblotting was carried 
out following standard protocols.  
  
Antibodies 
 
Anti-human Pkp3 hybridoma supernatant clone 11F2 was kindly provided 
by Dr. JK Wahl, 3rd. All other antibodies were purchased from commercial 
suppliers (mouse anti-c-myc, DSHB 9E 10; rabbit anti-myc, Santa Cruz SC-789; 
mouse anti-HA, 12CA5; rabbit anti-HA Santa Cruz SC-805; ETV1, Thermo 
Scientific MA5-15461; Pkp3, Progen 651113, GAPDH, Santa Cruz sc-25778, 
skeletal muscle, DSHB 12/101, and acetylated alpha-tubulin, Sigma T7451). 
Secondary antibodies were Alexa Fluor 488 labeled goat anti-rabbit antibody 
(Invitrogen), Alexa Fluor 555 labeled goat anti-mouse antibody (Invitrogen), HRP-
conjugated goat anti-rabbit IgG (Bio-Rad) and HRP-conjugated goat anti-mouse 
IgG (Bio-Rad).  
 
Antibodies generated against the recombinant (GST-tagged) N-terminal 
domain of Xenopus Pkp3 (amino acids 1-350; PTG labs), were affinity-purified 
110 
 
from rabbit crude serum. The Xenopus PKP2 antiserum was raised in guinea 
pigs using a cocktail consisting of three peptides (EWRSECDTRRPTL+C, 
RYRTASRARQNLSQQFRQDT+C, QDLHSTYKKSYKK+C) coupled to keyhole 
limpet hemocyanin.  
 
Immunoblotting of Xenopus extracts 
 
Embryos were harvested at the indicated developmental stages and 
immuno-blotting was performed following standard procedures using 1-0.2X 
0.2% KPL Block (KPL 71-83-00) [177].  
 
Cell culture 
 
Human HeLa and HEK 293T cells were cultured in DMEM (Invitrogen), 
using standard mammalian cell culture conditions [140]. Cells were transfected 
using either Lipofectamine-2000 (Invitrogen) or polyethylenimine (Polysciences, 
Inc. 9002-98-6) following the manufacturer’s instructions. Mouse wild type AB-1 
embryonic stem cells were cultured as previously described [178].  
 
Immunostaining and fluorescent imaging of cell lines 
 
HeLa cells were plated on glass coverslips and grown to either 60 or 90% 
confluence 24 hours post-transfection. Cells were washed three times in 1X PBS 
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at room temperature (RT) and then fixed in PBS with 4% paraformaldehyde for 
10 minutes at 4 C. Cells were then washed three times in 1X PBS at RT, before 
neutralizing the paraformaldehyde with 50mM NH4Cl for 10 minutes at RT. 
Following two additional washes with 1X PBS, the cells were permeabilized with 
0.5% Triton X-100 in PBS for 10 minutes at RT. Two 1X PBS washes preceded a 
one-hour RT incubation in blocking buffer (10% goat serum, 2mg/ml BSA, 0.1% 
Triton X-100 in 1X PBS). Cells were then incubated overnight at four degrees 
Celsius in blocking buffer containing primary antibody (1:500 dilutions of either 
anti-HA or anti-Myc). The next day, samples were washed 3X for 10 minutes 
each in 1X PBS. They were then incubated for 1 hour at RT with Alexa Flour® 
488 or 555 conjugated secondary antibodies (1:500). Three washes were 
performed prior to mounting with Vectashield® mounting medium (Vector 
Laboratories Cat. No. H-1000).  
 
Images were obtained with a Zeiss Observer Z1 confocal designed by 3i, 
Inc using Slidebook 5.5 software. To ensure loss of relocalization, images were 
adjusted for brightness in select cases using Adobe Photoshop software.  
 
Luciferase assay 
 
HEK 293T cells were co-transfected with the indicated plasmids and pRL-
SV40 renilla reporter plasmid (internal control). Cells were lysed and assayed 24 
hours later for luciferase activity using the Dual Luciferase® Reporter Assay 
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System, in accordance with the manufacturer’s protocol (Promega). All 
experiments were repeated a minimum of three times. 
 
Statistical Analysis 
 
Data presented is in percentages to account for differences in total 
numbers between each experimental condition. Graphs produced were based on 
the average percentages of triplicate experiments. To analyze the significance of 
our phenotypes, we used the Student’s T-test. To obtain P-values, we 
hypothesized that the two groups are statistically identical (null hypothesis), and 
analyzed the data using the Student’s T-test (TTEST) within the Microsoft Excel 
software program. 
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This chapter contains published work taken from Munoz WA, Kloc M, Cho 
K, Lee M, Hofmann I, Sater A, Vleminckx K, McCrea PD. (2012) Plakophilin-3 Is 
Required for Late Embryonic Amphibian Development, Exhibiting Roles in 
Ectodermal and Neural Tissues. PLoS ONE 7(4): e34342. 
doi:10.1371/journal.pone.0034342. 
 
Open access agreement. Upon submission of an article, its authors are asked 
to indicate their agreement to abide by an open access Creative Commons 
license (CC-BY). Under the terms of this license, authors retain ownership of the 
copyright of their articles. However, the license permits any user to download, 
print out, extract, reuse, archive, and distribute the article, so long as appropriate 
credit is given to the authors and source of the work. The license ensures that 
the authors' article will be available as widely as possible and that the article can 
be included in any scientific archive. 
114 
 
1. Takeichi M (1995) Morphogenetic roles of classic cadherins. Curr Opin Cell 
Biol 7: 619-627. 
2. Shapiro L, Weis WI (2009) Structure and biochemistry of cadherins and 
catenins. Cold Spring Harb Perspect Biol 1: a003053. 
3. Gumbiner BM (2005) Regulation of cadherin-mediated adhesion in 
morphogenesis. Nat Rev Mol Cell Biol 6: 622-634. 
4. Harris TJ, Tepass U (2010) Adherens junctions: from molecules to 
morphogenesis. Nat Rev Mol Cell Biol 11: 502-514. 
5. Reynolds AB, Carnahan RH (2004) Regulation of cadherin stability and 
turnover by p120ctn: implications in disease and cancer. Semin Cell Dev 
Biol 15: 657-663. 
6. Jeanes A, Gottardi CJ, Yap AS (2008) Cadherins and cancer: how does 
cadherin dysfunction promote tumor progression? Oncogene 27: 6920-
6929. 
7. Brooke MA, Nitoiu D, Kelsell DP (2012) Cell-cell connectivity: desmosomes 
and disease. J Pathol 226: 158-171. 
8. Chidgey M, Dawson C (2007) Desmosomes: a role in cancer? Br J Cancer 96: 
1783-1787. 
9. McGrath JA (2005) Inherited disorders of desmosomes. Australas J Dermatol 
46: 221-229. 
10. Thomason HA, Scothern A, McHarg S, Garrod DR (2010) Desmosomes: 
adhesive strength and signalling in health and disease. Biochem J 429: 
419-433. 
115 
 
11. Ozawa M, Baribault H, Kemler R (1989) The cytoplasmic domain of the cell 
adhesion molecule uvomorulin associates with three independent proteins 
structurally related in different species. EMBO J 8: 1711-1717. 
12. Heid HW, Schmidt A, Zimbelmann R, Schafer S, Winter-Simanowski S, 
Stumpp S, Keith M, Figge U, Schnolzer M, Franke WW (1994) Cell type-
specific desmosomal plaque proteins of the plakoglobin family: plakophilin 
1 (band 6 protein). Differentiation 58: 113-131. 
13. Huber AH, Nelson WJ, Weis WI (1997) Three-dimensional structure of the 
armadillo repeat region of beta-catenin. Cell 90: 871-882. 
14. Peifer M, Berg S, Reynolds AB (1994) A repeating amino acid motif shared 
by proteins with diverse cellular roles. Cell 76: 789-791. 
15. Choi HJ, Weis WI (2005) Structure of the armadillo repeat domain of 
plakophilin 1. J Mol Biol 346: 367-376. 
16. Bass-Zubek AE, Godsel LM, Delmar M, Green KJ (2009) Plakophilins: 
multifunctional scaffolds for adhesion and signaling. Curr Opin Cell Biol 
21: 708-716. 
17. Hatzfeld M (2007) Plakophilins: Multifunctional proteins or just regulators of 
desmosomal adhesion? Biochim Biophys Acta 1773: 69-77. 
18. McCrea PD, Gu D, Balda MS (2009) Junctional music that the nucleus hears: 
cell-cell contact signaling and the modulation of gene activity. Cold Spring 
Harb Perspect Biol 1: a002923. 
116 
 
19. Carnahan RH, Rokas A, Gaucher EA, Reynolds AB (2010) The molecular 
evolution of the p120-catenin subfamily and its functional associations. 
PLoS One 5: e15747. 
20. McCrea PD, Gu D (2010) The catenin family at a glance. J Cell Sci 123: 637-
642. 
21. Peifer M, McCrea PD, Green KJ, Wieschaus E, Gumbiner BM (1992) The 
vertebrate adhesive junction proteins beta-catenin and plakoglobin and 
the Drosophila segment polarity gene armadillo form a multigene family 
with similar properties. J Cell Biol 118: 681-691. 
22. Mariner DJ, Wang J, Reynolds AB (2000) ARVCF localizes to the nucleus 
and adherens junction and is mutually exclusive with p120(ctn) in E-
cadherin complexes. J Cell Sci 113 ( Pt 8): 1481-1490. 
23. Ohkubo T, Ozawa M (1999) p120(ctn) binds to the membrane-proximal 
region of the E-cadherin cytoplasmic domain and is involved in modulation 
of adhesion activity. J Biol Chem 274: 21409-21415. 
24. Ozawa M, Ringwald M, Kemler R (1990) Uvomorulin-catenin complex 
formation is regulated by a specific domain in the cytoplasmic region of 
the cell adhesion molecule. Proc Natl Acad Sci U S A 87: 4246-4250. 
25. Thoreson MA, Anastasiadis PZ, Daniel JM, Ireton RC, Wheelock MJ, 
Johnson KR, Hummingbird DK, Reynolds AB (2000) Selective uncoupling 
of p120(ctn) from E-cadherin disrupts strong adhesion. J Cell Biol 148: 
189-202. 
117 
 
26. Yap AS, Niessen CM, Gumbiner BM (1998) The juxtamembrane region of the 
cadherin cytoplasmic tail supports lateral clustering, adhesive 
strengthening, and interaction with p120ctn. J Cell Biol 141: 779-789. 
27. Meng W, Takeichi M (2009) Adherens junction: molecular architecture and 
regulation. Cold Spring Harb Perspect Biol 1: a002899. 
28. Chen X, Bonne S, Hatzfeld M, van Roy F, Green KJ (2002) Protein binding 
and functional characterization of plakophilin 2. Evidence for its diverse 
roles in desmosomes and beta -catenin signaling. J Biol Chem 277: 
10512-10522. 
29. Hatzfeld M, Haffner C, Schulze K, Vinzens U (2000) The function of 
plakophilin 1 in desmosome assembly and actin filament organization. J 
Cell Biol 149: 209-222. 
30. Knudsen KA, Wheelock MJ (1992) Plakoglobin, or an 83-kD homologue 
distinct from beta-catenin, interacts with E-cadherin and N-cadherin. J Cell 
Biol 118: 671-679. 
31. Ireton RC, Davis MA, van Hengel J, Mariner DJ, Barnes K, Thoreson MA, 
Anastasiadis PZ, Matrisian L, Bundy LM, Sealy L, Gilbert B, van Roy F, 
Reynolds AB (2002) A novel role for p120 catenin in E-cadherin function. J 
Cell Biol 159: 465-476. 
32. Bass-Zubek AE, Hobbs RP, Amargo EV, Garcia NJ, Hsieh SN, Chen X, Wahl 
JK, 3rd, Denning MF, Green KJ (2008) Plakophilin 2: a critical scaffold for 
PKC alpha that regulates intercellular junction assembly. J Cell Biol 181: 
605-613. 
118 
 
33. Davis MA, Ireton RC, Reynolds AB (2003) A core function for p120-catenin in 
cadherin turnover. J Cell Biol 163: 525-534. 
34. Gu D, Sater AK, Ji H, Cho K, Clark M, Stratton SA, Barton MC, Lu Q, McCrea 
PD (2009) Xenopus delta-catenin is essential in early embryogenesis and 
is functionally linked to cadherins and small GTPases. J Cell Sci 122: 
4049-4061. 
35. Bryant DM, Stow JL (2004) The ins and outs of E-cadherin trafficking. Trends 
Cell Biol 14: 427-434. 
36. Xiao K, Oas RG, Chiasson CM, Kowalczyk AP (2007) Role of p120-catenin in 
cadherin trafficking. Biochim Biophys Acta 1773: 8-16. 
37. Xiao K, Garner J, Buckley KM, Vincent PA, Chiasson CM, Dejana E, 
Faundez V, Kowalczyk AP (2005) p120-Catenin regulates clathrin-
dependent endocytosis of VE-cadherin. Mol Biol Cell 16: 5141-5151. 
38. Yin T, Green KJ (2004) Regulation of desmosome assembly and adhesion. 
Semin Cell Dev Biol 15: 665-677. 
39. Sobolik-Delmaire T, Katafiasz D, Wahl JK, 3rd (2006) Carboxyl terminus of 
Plakophilin-1 recruits it to plasma membrane, whereas amino terminus 
recruits desmoplakin and promotes desmosome assembly. J Biol Chem 
281: 16962-16970. 
40. Schmidt A, Jager S (2005) Plakophilins--hard work in the desmosome, 
recreation in the nucleus? Eur J Cell Biol 84: 189-204. 
119 
 
41. Nekrasova OE, Amargo EV, Smith WO, Chen J, Kreitzer GE, Green KJ 
(2011) Desmosomal cadherins utilize distinct kinesins for assembly into 
desmosomes. J Cell Biol 195: 1185-1203. 
42. Godsel LM, Dubash AD, Bass-Zubek AE, Amargo EV, Klessner JL, Hobbs 
RP, Chen X, Green KJ (2010) Plakophilin 2 couples actomyosin 
remodeling to desmosomal plaque assembly via RhoA. Mol Biol Cell 21: 
2844-2859. 
43. Abe K, Takeichi M (2008) EPLIN mediates linkage of the cadherin catenin 
complex to F-actin and stabilizes the circumferential actin belt. Proc Natl 
Acad Sci U S A 105: 13-19. 
44. Pappas DJ, Rimm DL (2006) Direct interaction of the C-terminal domain of 
alpha-catenin and F-actin is necessary for stabilized cell-cell adhesion. 
Cell Commun Adhes 13: 151-170. 
45. Bonne S, Gilbert B, Hatzfeld M, Chen X, Green KJ, van Roy F (2003) 
Defining desmosomal plakophilin-3 interactions. J Cell Biol 161: 403-416. 
46. Smith EA, Fuchs E (1998) Defining the interactions between intermediate 
filaments and desmosomes. J Cell Biol 141: 1229-1241. 
47. Hartsock A, Nelson WJ (2008) Adherens and tight junctions: structure, 
function and connections to the actin cytoskeleton. Biochim Biophys Acta 
1778: 660-669. 
48. Anastasiadis PZ (2007) p120-ctn: A nexus for contextual signaling via Rho 
GTPases. Biochim Biophys Acta 1773: 34-46. 
120 
 
49. Fang X, Ji H, Kim SW, Park JI, Vaught TG, Anastasiadis PZ, Ciesiolka M, 
McCrea PD (2004) Vertebrate development requires ARVCF and p120 
catenins and their interplay with RhoA and Rac. J Cell Biol 165: 87-98. 
50. Grosheva I, Shtutman M, Elbaum M, Bershadsky AD (2001) p120 catenin 
affects cell motility via modulation of activity of Rho-family GTPases: a link 
between cell-cell contact formation and regulation of cell locomotion. J 
Cell Sci 114: 695-707. 
51. Keil R, Wolf A, Huttelmaier S, Hatzfeld M (2007) Beyond regulation of cell 
adhesion: local control of RhoA at the cleavage furrow by the p0071 
catenin. Cell Cycle 6: 122-127. 
52. Noren NK, Liu BP, Burridge K, Kreft B (2000) p120 catenin regulates the 
actin cytoskeleton via Rho family GTPases. J Cell Biol 150: 567-580. 
53. Wolf A, Keil R, Gotzl O, Mun A, Schwarze K, Lederer M, Huttelmaier S, 
Hatzfeld M (2006) The armadillo protein p0071 regulates Rho signalling 
during cytokinesis. Nat Cell Biol 8: 1432-1440. 
54. Anastasiadis PZ, Moon SY, Thoreson MA, Mariner DJ, Crawford HC, Zheng 
Y, Reynolds AB (2000) Inhibition of RhoA by p120 catenin. Nat Cell Biol 2: 
637-644. 
55. Furukawa C, Daigo Y, Ishikawa N, Kato T, Ito T, Tsuchiya E, Sone S, 
Nakamura Y (2005) Plakophilin 3 oncogene as prognostic marker and 
therapeutic target for lung cancer. Cancer Res 65: 7102-7110. 
121 
 
56. Koetsier JL, Amargo EV, Todorovic V, Green KJ, Godsel LM (2013) 
Plakophilin 2 Affects Cell Migration by Modulating Focal Adhesion 
Dynamics and Integrin Protein Expression. J Invest Dermatol. 
57. Daniel JM (2007) Dancing in and out of the nucleus: p120(ctn) and the 
transcription factor Kaiso. Biochim Biophys Acta 1773: 59-68. 
58. Daniel JM, Reynolds AB (1999) The catenin p120(ctn) interacts with Kaiso, a 
novel BTB/POZ domain zinc finger transcription factor. Mol Cell Biol 19: 
3614-3623. 
59. Molenaar M, van de Wetering M, Oosterwegel M, Peterson-Maduro J, 
Godsave S, Korinek V, Roose J, Destree O, Clevers H (1996) XTcf-3 
transcription factor mediates beta-catenin-induced axis formation in 
Xenopus embryos. Cell 86: 391-399. 
60. Hosking CR, Ulloa F, Hogan C, Ferber EC, Figueroa A, Gevaert K, 
Birchmeier W, Briscoe J, Fujita Y (2007) The transcriptional repressor 
Glis2 is a novel binding partner for p120 catenin. Mol Biol Cell 18: 1918-
1927. 
61. Kim SW, Park JI, Spring CM, Sater AK, Ji H, Otchere AA, Daniel JM, McCrea 
PD (2004) Non-canonical Wnt signals are modulated by the Kaiso 
transcriptional repressor and p120-catenin. Nat Cell Biol 6: 1212-1220. 
62. Park JI, Kim SW, Lyons JP, Ji H, Nguyen TT, Cho K, Barton MC, Deroo T, 
Vleminckx K, Moon RT, McCrea PD (2005) Kaiso/p120-catenin and 
TCF/beta-catenin complexes coordinately regulate canonical Wnt gene 
targets. Dev Cell 8: 843-854. 
122 
 
63. Iioka H, Doerner SK, Tamai K (2009) Kaiso is a bimodal modulator for 
Wnt/beta-catenin signaling. FEBS Lett 583: 627-632. 
64. Spring CM, Kelly KF, O'Kelly I, Graham M, Crawford HC, Daniel JM (2005) 
The catenin p120ctn inhibits Kaiso-mediated transcriptional repression of 
the beta-catenin/TCF target gene matrilysin. Exp Cell Res 305: 253-265. 
65. Park JI, Ji H, Jun S, Gu D, Hikasa H, Li L, Sokol SY, McCrea PD (2006) 
Frodo links Dishevelled to the p120-catenin/Kaiso pathway: distinct 
catenin subfamilies promote Wnt signals. Dev Cell 11: 683-695. 
66. Daniel JM, Spring CM, Crawford HC, Reynolds AB, Baig A (2002) The 
p120(ctn)-binding partner Kaiso is a bi-modal DNA-binding protein that 
recognizes both a sequence-specific consensus and methylated CpG 
dinucleotides. Nucleic Acids Res 30: 2911-2919. 
67. Bergman R, Sprecher E (2005) Histopathological and ultrastructural study of 
ectodermal dysplasia/skin fragility syndrome. Am J Dermatopathol 27: 
333-338. 
68. McGrath JA, McMillan JR, Shemanko CS, Runswick SK, Leigh IM, Lane EB, 
Garrod DR, Eady RA (1997) Mutations in the plakophilin 1 gene result in 
ectodermal dysplasia/skin fragility syndrome. Nat Genet 17: 240-244. 
69. McGrath JA, Mellerio JE (2010) Ectodermal dysplasia-skin fragility syndrome. 
Dermatol Clin 28: 125-129. 
70. Sprecher E, Molho-Pessach V, Ingber A, Sagi E, Indelman M, Bergman R 
(2004) Homozygous splice site mutations in PKP1 result in loss of 
epidermal plakophilin 1 expression and underlie ectodermal dysplasia/skin 
123 
 
fragility syndrome in two consanguineous families. J Invest Dermatol 122: 
647-651. 
71. Wessagowit V, McGrath JA (2005) Clinical and molecular significance of 
splice site mutations in the plakophilin 1 gene in patients with ectodermal 
dysplasia-skin fragility syndrome. Acta Derm Venereol 85: 386-388. 
72. Whittock NV, Haftek M, Angoulvant N, Wolf F, Perrot H, Eady RA, McGrath 
JA (2000) Genomic amplification of the human plakophilin 1 gene and 
detection of a new mutation in ectodermal dysplasia/skin fragility 
syndrome. J Invest Dermatol 115: 368-374. 
73. Awad MM, Calkins H, Judge DP (2008) Mechanisms of disease: molecular 
genetics of arrhythmogenic right ventricular dysplasia/cardiomyopathy. 
Nat Clin Pract Cardiovasc Med 5: 258-267. 
74. Gerull B, Heuser A, Wichter T, Paul M, Basson CT, McDermott DA, Lerman 
BB, Markowitz SM, Ellinor PT, MacRae CA, Peters S, Grossmann KS, 
Drenckhahn J, Michely B, Sasse-Klaassen S, Birchmeier W, Dietz R, 
Breithardt G, Schulze-Bahr E, Thierfelder L (2004) Mutations in the 
desmosomal protein plakophilin-2 are common in arrhythmogenic right 
ventricular cardiomyopathy. Nat Genet 36: 1162-1164. 
75. Grossmann KS, Grund C, Huelsken J, Behrend M, Erdmann B, Franke WW, 
Birchmeier W (2004) Requirement of plakophilin 2 for heart 
morphogenesis and cardiac junction formation. J Cell Biol 167: 149-160. 
124 
 
76. Hall C, Li S, Li H, Creason V, Wahl JK, 3rd (2009) Arrhythmogenic right 
ventricular cardiomyopathy plakophilin-2 mutations disrupt desmosome 
assembly and stability. Cell Commun Adhes 16: 15-27. 
77. Breuninger S, Reidenbach S, Sauer CG, Strobel P, Pfitzenmaier J, Trojan L, 
Hofmann I (2010) Desmosomal plakophilins in the prostate and prostatic 
adenocarcinomas: implications for diagnosis and tumor progression. Am J 
Pathol 176: 2509-2519. 
78. Kundu ST, Gosavi P, Khapare N, Patel R, Hosing AS, Maru GB, Ingle A, 
Decaprio JA, Dalal SN (2008) Plakophilin3 downregulation leads to a 
decrease in cell adhesion and promotes metastasis. Int J Cancer 123: 
2303-2314. 
79. Schwarz J, Ayim A, Schmidt A, Jager S, Koch S, Baumann R, Dunne AA, 
Moll R (2006) Differential expression of desmosomal plakophilins in 
various types of carcinomas: correlation with cell type and differentiation. 
Hum Pathol 37: 613-622. 
80. Wolf A, Rietscher K, Glass M, Huttelmaier S, Schutkowski M, Ihling C, Sinz 
A, Wingenfeld A, Mun A, Hatzfeld M (2013) Insulin signaling via Akt2 
switches plakophilin 1 function from stabilizing cell adhesion to promoting 
cell proliferation. J Cell Sci 126: 1832-1844. 
81. Carnahan RH, Rokas A, Gaucher EA, Reynolds AB The molecular evolution 
of the p120-catenin subfamily and its functional associations. PLoS One 5: 
e15747. 
125 
 
82. McCrea PD, Park JI (2007) Developmental functions of the P120-catenin 
sub-family. Biochim Biophys Acta 1773: 17-33. 
83. South AP, Wan H, Stone MG, Dopping-Hepenstal PJ, Purkis PE, Marshall 
JF, Leigh IM, Eady RA, Hart IR, McGrath JA (2003) Lack of plakophilin 1 
increases keratinocyte migration and reduces desmosome stability. J Cell 
Sci 116: 3303-3314. 
84. Hofmann I, Mertens C, Brettel M, Nimmrich V, Schnolzer M, Herrmann H 
(2000) Interaction of plakophilins with desmoplakin and intermediate 
filament proteins: an in vitro analysis. J Cell Sci 113 ( Pt 13): 2471-2483. 
85. Kowalczyk AP, Hatzfeld M, Bornslaeger EA, Kopp DS, Borgwardt JE, 
Corcoran CM, Settler A, Green KJ (1999) The head domain of plakophilin-
1 binds to desmoplakin and enhances its recruitment to desmosomes. 
Implications for cutaneous disease. J Biol Chem 274: 18145-18148. 
86. Hobbs RP, Green KJ (2012) Desmoplakin Regulates Desmosome 
Hyperadhesion. J Invest Dermatol 132: 482-485. 
87. Roberts BJ, Pashaj A, Johnson KR, Wahl JK, 3rd (2011) Desmosome 
dynamics in migrating epithelial cells requires the actin cytoskeleton. Exp 
Cell Res 317: 2814-2822. 
88. Hofmann I, Casella M, Schnolzer M, Schlechter T, Spring H, Franke WW 
(2006) Identification of the junctional plaque protein plakophilin 3 in 
cytoplasmic particles containing RNA-binding proteins and the recruitment 
of plakophilins 1 and 3 to stress granules. Mol Biol Cell 17: 1388-1398. 
126 
 
89. Wolf A, Krause-Gruszczynska M, Birkenmeier O, Ostareck-Lederer A, 
Huttelmaier S, Hatzfeld M (2010) Plakophilin 1 stimulates translation by 
promoting eIF4A1 activity. J Cell Biol 188: 463-471. 
90. Munoz WA, Kloc M, Cho K, Lee M, Hofmann I, Sater A, Vleminckx K, 
McCrea PD (2012) Plakophilin-3 is required for late embryonic amphibian 
development, exhibiting roles in ectodermal and neural tissues. PLoS One 
7: e34342. 
91. Schmidt A, Langbein L, Rode M, Pratzel S, Zimbelmann R, Franke WW 
(1997) Plakophilins 1a and 1b: widespread nuclear proteins recruited in 
specific epithelial cells as desmosomal plaque components. Cell Tissue 
Res 290: 481-499. 
92. Sobolik-Delmaire T, Reddy R, Pashaj A, Roberts BJ, Wahl JK, 3rd (2010) 
Plakophilin-1 localizes to the nucleus and interacts with single-stranded 
DNA. J Invest Dermatol 130: 2638-2646. 
93. Bonne S, van Hengel J, Nollet F, Kools P, van Roy F (1999) Plakophilin-3, a 
novel armadillo-like protein present in nuclei and desmosomes of epithelial 
cells. J Cell Sci 112 ( Pt 14): 2265-2276. 
94. Mertens C, Kuhn C, Franke WW (1996) Plakophilins 2a and 2b: constitutive 
proteins of dual location in the karyoplasm and the desmosomal plaque. J 
Cell Biol 135: 1009-1025. 
95. Klymkowsky MW (1999) Plakophilin, armadillo repeats, and nuclear 
localization. Microsc Res Tech 45: 43-54. 
127 
 
96. Beausoleil SA, Jedrychowski M, Schwartz D, Elias JE, Villen J, Li J, Cohn 
MA, Cantley LC, Gygi SP (2004) Large-scale characterization of HeLa cell 
nuclear phosphoproteins. Proc Natl Acad Sci U S A 101: 12130-12135. 
97. Mertens C, Hofmann I, Wang Z, Teichmann M, Sepehri Chong S, Schnolzer 
M, Franke WW (2001) Nuclear particles containing RNA polymerase III 
complexes associated with the junctional plaque protein plakophilin 2. 
Proc Natl Acad Sci U S A 98: 7795-7800. 
98. Sobolik-Delmaire T, Reddy R, Pashaj A, Roberts BJ, Wahl JK, 3rd 
Plakophilin-1 localizes to the nucleus and interacts with single-stranded 
DNA. J Invest Dermatol 130: 2638-2646. 
99. Schmidt A, Langbein L, Pratzel S, Rode M, Rackwitz HR, Franke WW (1999) 
Plakophilin 3--a novel cell-type-specific desmosomal plaque protein. 
Differentiation 64: 291-306. 
100. North AJ, Bardsley WG, Hyam J, Bornslaeger EA, Cordingley HC, 
Trinnaman B, Hatzfeld M, Green KJ, Magee AI, Garrod DR (1999) 
Molecular map of the desmosomal plaque. J Cell Sci 112 ( Pt 23): 4325-
4336. 
101. Edgar R, Domrachev M, Lash AE (2002) Gene Expression Omnibus: NCBI 
gene expression and hybridization array data repository. Nucleic Acids 
Res 30: 207-210. 
102. Sklyarova T, Bonne S, D'Hooge P, Denecker G, Goossens S, De Rycke R, 
Borgonie G, Bosl M, van Roy F, van Hengel J (2008) Plakophilin-3-
128 
 
deficient mice develop hair coat abnormalities and are prone to cutaneous 
inflammation. J Invest Dermatol 128: 1375-1385. 
103. Papagerakis S, Shabana AH, Depondt J, Gehanno P, Forest N (2003) 
Immunohistochemical localization of plakophilins (PKP1, PKP2, PKP3, 
and p0071) in primary oropharyngeal tumors: correlation with clinical 
parameters. Hum Pathol 34: 565-572. 
104. Demirag GG, Sullu Y, Gurgenyatagi D, Okumus NO, Yucel I (2011) 
Expression of plakophilins (PKP1, PKP2, and PKP3) in gastric cancers. 
Diagn Pathol 6: 1. 
105. Demirag GG, Sullu Y, Yucel I (2012) Expression of Plakophilins (PKP1, 
PKP2, and PKP3) in breast cancers. Med Oncol 29: 1518-1522. 
106. Degnan BM, Degnan SM, Naganuma T, Morse DE (1993) The ets 
multigene family is conserved throughout the Metazoa. Nucleic Acids Res 
21: 3479-3484. 
107. Karim FD, Urness LD, Thummel CS, Klemsz MJ, McKercher SR, Celada A, 
Van Beveren C, Maki RA, Gunther CV, Nye JA, et al. (1990) The ETS-
domain: a new DNA-binding motif that recognizes a purine-rich core DNA 
sequence. Genes Dev 4: 1451-1453. 
108. Laudet V, Niel C, Duterque-Coquillaud M, Leprince D, Stehelin D (1993) 
Evolution of the ets gene family. Biochem Biophys Res Commun 190: 8-
14. 
129 
 
109. Liang H, Mao X, Olejniczak ET, Nettesheim DG, Yu L, Meadows RP, 
Thompson CB, Fesik SW (1994) Solution structure of the ets domain of 
Fli-1 when bound to DNA. Nat Struct Biol 1: 871-875. 
110. Sharrocks AD (2001) The ETS-domain transcription factor family. Nat Rev 
Mol Cell Biol 2: 827-837. 
111. Hollenhorst PC, McIntosh LP, Graves BJ (2011) Genomic and biochemical 
insights into the specificity of ETS transcription factors. Annu Rev 
Biochem 80: 437-471. 
112. Hart AH, Reventar R, Bernstein A (2000) Genetic analysis of ETS genes in 
C. elegans. Oncogene 19: 6400-6408. 
113. Hsu T, Schulz RA (2000) Sequence and functional properties of Ets genes 
in the model organism Drosophila. Oncogene 19: 6409-6416. 
114. Wei GH, Badis G, Berger MF, Kivioja T, Palin K, Enge M, Bonke M, Jolma 
A, Varjosalo M, Gehrke AR, Yan J, Talukder S, Turunen M, Taipale M, 
Stunnenberg HG, Ukkonen E, Hughes TR, Bulyk ML, Taipale J (2010) 
Genome-wide analysis of ETS-family DNA-binding in vitro and in vivo. 
EMBO J 29: 2147-2160. 
115. Brass AL, Zhu AQ, Singh H (1999) Assembly requirements of PU.1-Pip 
(IRF-4) activator complexes: inhibiting function in vivo using fused dimers. 
EMBO J 18: 977-991. 
116. de Launoit Y, Baert JL, Chotteau A, Monte D, Defossez PA, Coutte L, 
Pelczar H, Leenders F (1997) Structure-function relationships of the PEA3 
group of Ets-related transcription factors. Biochem Mol Med 61: 127-135. 
130 
 
117. Greenall A, Willingham N, Cheung E, Boam DS, Sharrocks AD (2001) DNA 
binding by the ETS-domain transcription factor PEA3 is regulated by 
intramolecular and intermolecular protein.protein interactions. J Biol Chem 
276: 16207-16215. 
118. Bojovic BB, Hassell JA (2001) The PEA3 Ets transcription factor comprises 
multiple domains that regulate transactivation and DNA binding. J Biol 
Chem 276: 4509-4521. 
119. Lin JH, Saito T, Anderson DJ, Lance-Jones C, Jessell TM, Arber S (1998) 
Functionally related motor neuron pool and muscle sensory afferent 
subtypes defined by coordinate ETS gene expression. Cell 95: 393-407. 
120. Arber S, Ladle DR, Lin JH, Frank E, Jessell TM (2000) ETS gene Er81 
controls the formation of functional connections between group Ia sensory 
afferents and motor neurons. Cell 101: 485-498. 
121. Laing MA, Coonrod S, Hinton BT, Downie JW, Tozer R, Rudnicki MA, 
Hassell JA (2000) Male sexual dysfunction in mice bearing targeted 
mutant alleles of the PEA3 ets gene. Mol Cell Biol 20: 9337-9345. 
122. Hagedorn L, Paratore C, Brugnoli G, Baert JL, Mercader N, Suter U, 
Sommer L (2000) The Ets domain transcription factor Erm distinguishes 
rat satellite glia from Schwann cells and is regulated in satellite cells by 
neuregulin signaling. Dev Biol 219: 44-58. 
123. Flames N, Hobert O (2009) Gene regulatory logic of dopamine neuron 
differentiation. Nature 458: 885-889. 
131 
 
124. Chen Y, Hollemann T, Grunz H, Pieler T (1999) Characterization of the Ets-
type protein ER81 in Xenopus embryos. Mech Dev 80: 67-76. 
125. Shin S, Oh S, An S, Janknecht R (2013) ETS variant 1 regulates matrix 
metalloproteinase-7 transcription in LNCaP prostate cancer cells. Oncol 
Rep 29: 306-314. 
126. Fuchs B, Inwards CY, Janknecht R (2003) Upregulation of the matrix 
metalloproteinase-1 gene by the Ewing's sarcoma associated EWS-ER81 
and EWS-Fli-1 oncoproteins, c-Jun and p300. FEBS Lett 553: 104-108. 
127. Oh S, Shin S, Janknecht R (2012) ETV1, 4 and 5: an oncogenic subfamily 
of ETS transcription factors. Biochim Biophys Acta 1826: 1-12. 
128. Aho S, Levansuo L, Montonen O, Kari C, Rodeck U, Uitto J (2002) Specific 
sequences in p120ctn determine subcellular distribution of its multiple 
isoforms involved in cellular adhesion of normal and malignant epithelial 
cells. J Cell Sci 115: 1391-1402. 
129. Gu D, Tonthat NK, Lee M, Ji H, Bhat KP, Hollingsworth F, Aldape KD, 
Schumacher MA, Zwaka TP, McCrea PD Caspase-3 cleavage links delta-
catenin to the novel nuclear protein ZIFCAT. J Biol Chem. 
130. Paulson AF, Mooney E, Fang X, Ji H, McCrea PD (2000) Xarvcf, Xenopus 
member of the p120 catenin subfamily associating with cadherin 
juxtamembrane region. J Biol Chem 275: 30124-30131. 
131. Ciesiolka M, Delvaeye M, Van Imschoot G, Verschuere V, McCrea P, van 
Roy F, Vleminckx K (2004) p120 catenin is required for morphogenetic 
132 
 
movements involved in the formation of the eyes and the craniofacial 
skeleton in Xenopus. J Cell Sci 117: 4325-4339. 
132. Schneider S, Herrenknecht K, Butz S, Kemler R, Hausen P (1993) Catenins 
in Xenopus embryogenesis and their relation to the cadherin-mediated 
cell-cell adhesion system. Development 118: 629-640. 
133. DeMarais AA, Moon RT (1992) The armadillo homologs beta-catenin and 
plakoglobin are differentially expressed during early development of 
Xenopus laevis. Dev Biol 153: 337-346. 
134. Mo YY, Reynolds AB (1996) Identification of murine p120 isoforms and 
heterogeneous expression of p120cas isoforms in human tumor cell lines. 
Cancer Res 56: 2633-2640. 
135. Keirsebilck A, Bonne S, Staes K, van Hengel J, Nollet F, Reynolds A, van 
Roy F (1998) Molecular cloning of the human p120ctn catenin gene 
(CTNND1): expression of multiple alternatively spliced isoforms. 
Genomics 50: 129-146. 
136. Munchberg SR, Steinbeisser H (1999) The Xenopus Ets transcription factor 
XER81 is a target of the FGF signaling pathway. Mech Dev 80: 53-65. 
137. de Nooij JC, Doobar S, Jessell TM (2013) Etv1 inactivation reveals 
proprioceptor subclasses that reflect the level of NT3 expression in muscle 
targets. Neuron 77: 1055-1068. 
138. Abe H, Okazawa M, Nakanishi S (2011) The Etv1/Er81 transcription factor 
orchestrates activity-dependent gene regulation in the terminal maturation 
133 
 
program of cerebellar granule cells. Proc Natl Acad Sci U S A 108: 12497-
12502. 
139. Gallicano GI, Bauer C, Fuchs E (2001) Rescuing desmoplakin function in 
extra-embryonic ectoderm reveals the importance of this protein in 
embryonic heart, neuroepithelium, skin and vasculature. Development 
128: 929-941. 
140. Cho K, Vaught TG, Ji H, Gu D, Papasakelariou-Yared C, Horstmann N, 
Jennings JM, Lee M, Sevilla LM, Kloc M, Reynolds AB, Watt FM, Brennan 
RG, Kowalczyk AP, McCrea PD (2010) Xenopus Kazrin interacts with 
ARVCF-catenin, spectrin and p190B RhoGAP, and modulates RhoA 
activity and epithelial integrity. J Cell Sci 123: 4128-4144. 
141. Paratore C, Brugnoli G, Lee HY, Suter U, Sommer L (2002) The role of the 
Ets domain transcription factor Erm in modulating differentiation of neural 
crest stem cells. Dev Biol 250: 168-180. 
142. de Launoit Y, Audette M, Pelczar H, Plaza S, Baert JL (1998) The 
transcription of the intercellular adhesion molecule-1 is regulated by Ets 
transcription factors. Oncogene 16: 2065-2073. 
143. Ray-Gallet D, Mao C, Tavitian A, Moreau-Gachelin F (1995) DNA binding 
specificities of Spi-1/PU.1 and Spi-B transcription factors and identification 
of a Spi-1/Spi-B binding site in the c-fes/c-fps promoter. Oncogene 11: 
303-313. 
144. Chi P, Chen Y, Zhang L, Guo X, Wongvipat J, Shamu T, Fletcher JA, 
Dewell S, Maki RG, Zheng D, Antonescu CR, Allis CD, Sawyers CL 
134 
 
(2010) ETV1 is a lineage survival factor that cooperates with KIT in 
gastrointestinal stromal tumours. Nature 467: 849-853. 
145. Bosc DG, Goueli BS, Janknecht R (2001) HER2/Neu-mediated activation of 
the ETS transcription factor ER81 and its target gene MMP-1. Oncogene 
20: 6215-6224. 
146. Cai C, Hsieh CL, Shemshedini L (2007) c-Jun has multiple enhancing 
activities in the novel cross talk between the androgen receptor and Ets 
variant gene 1 in prostate cancer. Mol Cancer Res 5: 725-735. 
147. Gu D, Tonthat NK, Lee M, Ji H, Bhat KP, Hollingsworth F, Aldape KD, 
Schumacher MA, Zwaka TP, McCrea PD (2011) Caspase-3 cleavage 
links delta-catenin to the novel nuclear protein ZIFCAT. J Biol Chem 286: 
23178-23188. 
148. Achtstatter T, Fouquet B, Rungger-Brandle E, Franke WW (1989) 
Cytokeratin filaments and desmosomes in the epithelioid cells of the 
perineurial and arachnoidal sheaths of some vertebrate species. 
Differentiation 40: 129-149. 
149. Funayama N, Fagotto F, McCrea P, Gumbiner BM (1995) Embryonic axis 
induction by the armadillo repeat domain of beta-catenin: evidence for 
intracellular signaling. J Cell Biol 128: 959-968. 
150. Klaus A, Birchmeier W (2008) Wnt signalling and its impact on development 
and cancer. Nat Rev Cancer 8: 387-398. 
151. Clevers H (2006) Wnt/beta-catenin signaling in development and disease. 
Cell 127: 469-480. 
135 
 
152. Hong JY, Park JI, Cho K, Gu D, Ji H, Artandi SE, McCrea PD (2010) Shared 
molecular mechanisms regulate multiple catenin proteins: canonical Wnt 
signals and components modulate p120-catenin isoform-1 and additional 
p120 subfamily members. J Cell Sci 123: 4351-4365. 
153. Israely I, Costa RM, Xie CW, Silva AJ, Kosik KS, Liu X (2004) Deletion of 
the neuron-specific protein delta-catenin leads to severe cognitive and 
synaptic dysfunction. Curr Biol 14: 1657-1663. 
154. Sive HL, R.M. Grainger, and R.M. Harland (2000) Early Development of 
Xenopus laevis - a Laboratory Manual. Cold Spring Harbor: Cold Spring 
Harbor Laboratory Press. 
155. McMillan JR, Haftek M, Akiyama M, South AP, Perrot H, McGrath JA, Eady 
RA, Shimizu H (2003) Alterations in desmosome size and number 
coincide with the loss of keratinocyte cohesion in skin with homozygous 
and heterozygous defects in the desmosomal protein plakophilin 1. J 
Invest Dermatol 121: 96-103. 
156. Green KJ, Simpson CL (2007) Desmosomes: new perspectives on a 
classic. J Invest Dermatol 127: 2499-2515. 
157. Snider P, Olaopa M, Firulli AB, Conway SJ (2007) Cardiovascular 
development and the colonizing cardiac neural crest lineage. 
ScientificWorldJournal 7: 1090-1113. 
158. Nolze A, Schneider J, Keil R, Lederer M, Huttelmaier S, Kessels MM, 
Qualmann B, Hatzfeld M (2013) FMRP regulates actin filament 
organization via the armadillo protein p0071. RNA 19: 1483-1496. 
136 
 
159. Clarke JD, Hayes BP, Hunt SP, Roberts A (1984) Sensory physiology, 
anatomy and immunohistochemistry of Rohon-Beard neurones in embryos 
of Xenopus laevis. J Physiol 348: 511-525. 
160. Kuriyama S, Mayor R (2008) Molecular analysis of neural crest migration. 
Philos Trans R Soc Lond B Biol Sci 363: 1349-1362. 
161. Christiansen JH, Coles EG, Wilkinson DG (2000) Molecular control of neural 
crest formation, migration and differentiation. Curr Opin Cell Biol 12: 719-
724. 
162. Basch ML, Bronner-Fraser M (2006) Neural crest inducing signals. Adv Exp 
Med Biol 589: 24-31. 
163. Pleger B, Ruff CC, Blankenburg F, Kloppel S, Driver J, Dolan RJ (2009) 
Influence of dopaminergically mediated reward on somatosensory 
decision-making. PLoS Biol 7: e1000164. 
164. Borrmann CM, Mertens C, Schmidt A, Langbein L, Kuhn C, Franke WW 
(2000) Molecular diversity of plaques of epithelial-adhering junctions. Ann 
N Y Acad Sci 915: 144-150. 
165. Hong JY, Park JI, Lee M, Munoz WA, Miller RK, Ji H, Gu D, Ezan J, Sokol 
SY, McCrea PD (2012) Down's-syndrome-related kinase Dyrk1A 
modulates the p120-catenin-Kaiso trajectory of the Wnt signaling pathway. 
J Cell Sci 125: 561-569. 
166. Miller RK, Hong JY, Munoz WA, McCrea PD (2013) Beta-catenin versus the 
other armadillo catenins: assessing our current view of canonical Wnt 
signaling. Prog Mol Biol Transl Sci 116: 387-407. 
137 
 
167. Saito-Diaz K, Chen TW, Wang X, Thorne CA, Wallace HA, Page-McCaw A, 
Lee E (2013) The way Wnt works: components and mechanism. Growth 
Factors 31: 1-31. 
168. Mosimann C, Hausmann G, Basler K (2009) Beta-catenin hits chromatin: 
regulation of Wnt target gene activation. Nat Rev Mol Cell Biol 10: 276-
286. 
169. Brown LA, Amores A, Schilling TF, Jowett T, Baert JL, de Launoit Y, 
Sharrocks AD (1998) Molecular characterization of the zebrafish PEA3 
ETS-domain transcription factor. Oncogene 17: 93-104. 
170. Oh S, Shin S, Lightfoot SA, Janknecht R (2013) 14-3-3 Proteins Modulate 
the ETS Transcription Factor ETV1 in Prostate Cancer. Cancer Res. 
171. Montross WT, Ji H, McCrea PD (2000) A beta-catenin/engrailed chimera 
selectively suppresses Wnt signaling. J Cell Sci 113 ( Pt 10): 1759-1770. 
172. Cho K, Lee M, Gu D, Munoz WA, Ji H, Kloc M, McCrea PD (2011) Kazrin, 
and its binding partners ARVCF- and delta-catenin, are required for 
Xenopus laevis craniofacial development. Dev Dyn 240: 2601-2612. 
173. Bilinski SM, Jaglarz MK, Dougherty MT, Kloc M (2010) Electron microscopy, 
immunostaining, cytoskeleton visualization, in situ hybridization, and 
three-dimensional reconstruction of Xenopus oocytes. Methods 51: 11-19. 
174. Wallingford JB (2010) Preparation of fixed Xenopus embryos for confocal 
imaging. Cold Spring Harb Protoc 2010: pdb prot5426. 
138 
 
175. Rain JC, Cribier A, Gerard A, Emiliani S, Benarous R (2009) Yeast two-
hybrid detection of integrase-host factor interactions. Methods 47: 291-
297. 
176. Hollenhorst PC, Ferris MW, Hull MA, Chae H, Kim S, Graves BJ (2011) 
Oncogenic ETS proteins mimic activated RAS/MAPK signaling in prostate 
cells. Genes Dev 25: 2147-2157. 
177. Miller RK, Canny SG, Jang CW, Cho K, Ji H, Wagner DS, Jones EA, Habas 
R, McCrea PD (2011) Pronephric tubulogenesis requires Daam1-
mediated planar cell polarity signaling. J Am Soc Nephrol 22: 1654-1664. 
178. Taube JH, Allton K, Duncan SA, Shen L, Barton MC (2010) Foxa1 functions 
as a pioneer transcription factor at transposable elements to activate Afp 
during differentiation of embryonic stem cells. J Biol Chem 285: 16135-
16144. 
 
 
139 
 
VITA 
 
 William Muñoz was born in Houston, Texas, on July 17th 1985 to 
Guillermo And Susan Muñoz. After attending Katy High School, he pursued a 
Bachelor’s of Science degree in Biochemistry at The University of Texas at 
Austin, which he earned in 2007. While pursuing his undergraduate studies he 
conducted research on the yeast deubiquitinating enzyme Ubp2 at The 
University of Texas at Austin Institute for Cellular and Molecular Biology. In 2007 
William initiated his Doctor of Philosophy studies in Biomedical Science at The 
University of Texas – Houston Graduate School of Biomedical Sciences. William 
currently lives with his wife, Jennifer Muñoz, J.D., in Kansas City, Missouri.  
 
 
Permanent address:  
20602 Cascading Brook Ct., Cypress, TX 77433 
